Systems and methods for diagnosing coronary microvascular disease

Information

  • Patent Grant
  • 12350018
  • Patent Number
    12,350,018
  • Date Filed
    Monday, May 4, 2020
    5 years ago
  • Date Issued
    Tuesday, July 8, 2025
    2 months ago
Abstract
The invention provides systems and methods for assessing the vasculature of a subject. In certain aspects, systems and methods of the invention involve receiving functional flow data of a subject via a data collector co-located with a radiopaque label, receiving imaging data of the vasculature including the radiopaque label, generating a vasculature map corresponding to the functional flow data, and displaying the vasculature map image on a monitor.
Description
TECHNICAL FIELD

This application generally relates to systems and methods for assessing vasculature of a subject.


BACKGROUND

Coronary microvascular disease, also known as small vessel disease, is a condition in which the small arteries in the heart become narrow. Typically, the walls of the small arteries are damaged or diseased. Coronary microvascular disease affects the vessels differently from traditional coronary artery disease. Coronary artery disease is an obstruction of blood flow through the coronary artery due to plaque accumulation and blood clots that form as a result of the accumulated plaque. However, the accumulation of plaque and resultant blockages are not always present in coronary microvasculature disease. Instead, coronary microvasculature disease is caused by an adverse constriction/relaxation of the small blood vessels. This adverse constriction/relation is believed to be caused by changes in the arterial cells and the surrounding muscle tissues. Coronary microvascular disease is especially problematic in women, who are more likely to experience the disease relative to men.


Diagnosing coronary microvascular disease has been a challenge. Conventional methods (such as angiography, stress test, and cardiac MRI stress test, etc.) are designed to detect blockages in the arteries. These tests are unable to consistently diagnose coronary microvascular disease because the small diseased vessels are often unrestricted by plaque, and thus are not visible on angiograms and MRI scans. Accordingly, women and other susceptible groups, such as diabetics, experiencing unexplainable fatigue, chest pain, or overall malaise associated with heart disease may test negative for heart disease.


SUMMARY

The invention overcomes the limitations of conventional methods for detecting coronary microvascular disease by mapping one or more functional flow measurements to an image of the vasculature. Functional flow measurements allow one to determine abnormal constriction or relaxation of blood vessels, even in the absence of a stenosis, by monitoring blood flow velocity and pressure. When functional flow measurements are mapped or co-registered to a vasculature image, one may determine the location and severity of damaged blood vessels that are otherwise not indicated in the vasculature image obtained by an external imaging modality.


Methods of the invention are accomplished by receiving functional flow data of a subject with a data collector co-located with a radiopaque label, and receiving imaging data of the vasculature including the radiopaque label. Using the received functional flow data and imaging data, a vasculature map image corresponding to the functional flow data is generated and displayed on a monitor. In certain embodiments, the vasculature map image corresponding to the functional flow data is generated by co-registering the functional flow data with the imaging data. By co-locating a radiopaque label with the data collector, it is easier to identify the exact location of the data collector and to correlate given functional flow measurements with a specific location within the vasculature. This makes possible systems that can simultaneously display functional flow measurements and pinpoint the location of those functional flow measurements on a corresponding vasculature map image.


Methods of the invention also provide for displaying a composite image including the vasculature map image and a functional flow image. The functional flow image may include the functional flow measurements specific to a certain location in the vasculature as shown on the vasculature map image. The vasculature map image may show a location of the data collector, which directly corresponds to the displayed functional flow image. In some embodiments, the location of the data collector is the real-time location of the data collector, e.g. the current location of the data collector as inserted in the vasculature.


According to certain aspects, methods of the invention further include analyzing the functional flow data for one or more parameters, and providing an alert on the vasculature map image when the one or more parameters are at or beyond a threshold level. In certain embodiments, the alert is a visual alert. The visual alert may include a color-coded indicator, a pulsating indicator, a color map of the one or more parameters, a callout marker, or a combination thereof.


The data collector may be located on a guidewire, catheter, or other intraluminal device configured to access the vasculature. Typically, the data collector for obtaining functional flow data is a pressure sensor, flow sensor, or combination thereof. Preferably, the intraluminal device is a guidewire with both a pressure sensor and a flow sensor on a distal portion of the device. Pressure sensors are able to obtain pressure measurements and flow sensors are able to obtain velocity measurements within a blood vessel. The ability to measure and compare both the pressure and flow significantly improves the diagnostic accuracy of ischemic testing.


The imaging data may be obtained using any external imaging modality, including e.g. computed tomography, angiography, and magnetic resonance imaging. When the external imaging modality requires flow contrast, the flow contrast may not enter the all of the vessels of the vasculature (such as the small vessels associated with coronary microvasculature disease) in adequate amounts for proper imaging, which may prevent mapping of vessels without contrast. Consequently, the external imaging modality used preferably does not require a flow contrast for imaging to increase the likelihood that the small vessels associated with coronary microvasculature disease are imaged and mapped.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic illustration of a system for implementing co-registration of functional flow data and external imaging data.



FIG. 2 shows depict a background vasculature image map obtained by an external imaging modality according to certain embodiments.



FIG. 3 depicts a composite image showing a vasculature map image corresponding to functional flow data and a functional flow image.



FIG. 4 depicts a simultaneous display of a functional flow image and a vasculature map image, highlighting via a box the location in which the functional flow image data was obtained.



FIG. 5 depicts an alternative simultaneous display of a functional flow image and a vasculature map image, highlighting the location in which the functional flow image data was obtained.



FIG. 6 indicates alerts according to certain embodiments. An arrow indicating the location of the data collector and lines visually linking the functional flow image to that location are given a different color if one or more parameters from the functional flow data at that location are at or above a threshold level for those one or more parameters.



FIG. 7 shows a color map of the vasculature image map for a parameter.



FIG. 8 is an image that simultaneously shows the functional flow image corresponding to point X from FIG. 7.



FIGS. 9A-9B show use of callout markers on the vasculature image map to signify areas of interest of the vasculature corresponding to the functional flow data.



FIG. 10 exemplifies a guidewire suitable for use with the present invention.



FIG. 11 is block diagram of a system of the invention for locating the position of a functional flow data relative to an image of the vasculature of the subject.



FIG. 12 is a block diagram of a networked system for locating the position of a functional flow data relative to an image of the vasculature of the subject.





DETAILED DESCRIPTION

Methods and systems of the invention include functional flow and image data acquisition equipment and data/image processors that generate views on a single display that simultaneously provides positional information and functional flow data associated with a data collector (e.g., a pressure sensor, flow sensor, temperature sensor, or combination thereof). The data collector is mounted upon a flexible elongate member (e.g, a catheter, guidewire, etc.) and co-located with a radiopaque label that can be tracked with an external imaging modality.


Turning initially to FIG. 1, an exemplary system is schematically depicted for carrying out the present invention in the form of co-registration of imaging data obtained from an external imaging modality and functional flow data obtained from a data collector. The external imaging modality data and functional flow data acquisition sub-systems are generally well known in the art. With regard to the external imaging modality data, a patient 10 is positioned upon a table 12 for imaging. The table 12 is arranged to provide sufficient space for the positioning of an external imaging modality 14 in an operative position in relation to the patient 10 on the table 12. Imaging data acquired by the external imaging modality 14 passes to an external imaging modality processor 18 via transmission cable 16. The imaging modality processor 18 converts the received imaging data received via the cable 16 into vasculature image data. The vasculature image data is initially stored within the processor 18.


With regard to portions of the system associated with acquiring functional flow data, an functional flow device 20 (preferably a pressure guidewire, flow guidewire, or combined pressure/flow guidewire) is inserted within the patient 10 so that its distal portion, including a data collector 22 (e.g. a pressure sensor, flow sensor, or both), is in the vicinity of a desired region of the vasculature. While not specifically identified in FIG. 1, a radiopaque label located near the data collector 22 provides indicia of a current location of the data collector 22 in an external image. By way of example, the data collector 22 may be a crystal semiconductor material that responds to pressure gradients and converts the pressure to corresponding electrical signals. The corresponding electrical signals are transmitted along the length of the functional flow device 20 to a proximal connector 24. Data collectors may come in a variety of configurations on the functional flow device. Regardless of the configuration, the radiopaque label should be co-located with the data collector, i.e. placed near or at the data collector. In some instances, the data collector itself may comprise a radiopaque material.


The proximal connector 24 of the functional flow device 20 is communicatively coupled to a functional flow data processor 26. The functional flow data processor 26 converts the signals received via the proximal connector 24 into, for example, pressure measurements, flow measurements, Fractional Flow Reserve measurements, Coronary Flow Reserve measurements, etc. Additionally, the functional flow processor 26 generates a functional flow image by converting the functional flow data into a displayable format. The functional flow data rendered by the functional flow processor 26 is initially stored within the processor 26.


The type of diagnostic functional flow data acquired by the data collector 22 and processed by the functional flow processor 26 varies in accordance with alternative embodiments of the invention. In accordance with a particular embodiment, the diagnostic probe 22 is equipped with one or more sensors (e.g., Doppler flow and/or pressure) for providing hemodynamic information (e.g., blood flow velocity and pressure)—also referred to as functional flow data. It is thus noted that the term “functional flow image” is intended to be broadly interpreted to encompass a variety of ways of representing vascular information including blood pressure, blood flow velocity/volume, blood vessel cross-sectional composition, shear stress throughout the blood, shear stress at the blood/blood vessel wall interface, etc. In the case of acquiring hemodynamic data for particular portions of a blood vessel, effective diagnosis relies upon the ability to visualize a current location of the data collector 22 within a vasculature while simultaneously observing functional flow metrics indicative of cardiovascular disease. Co-registration of hemodynamic and external vasculature images facilitates precise treatment of diseased vessels. In addition, it is contemplated that the functional flow device includes one or more imaging collector to provide, for example, cross-sectional images of the vasculature along with the functional flow data. Data obtained by the imaging collectors may also be processed by the functional flow processor 26 and co-registered with the external imaging data.


A co-registration processor 30 receives functional flow data from the functional flow processor 26 via line 32 and vasculature image data from the external imaging modality processor 18 via line 34. Alternatively, the communications between the sensors and the processors are carried out via wireless media. The co-registration processor 30 renders a vasculature map image corresponding to the functional flow data. For example, a vasculature map image is provided showing a location of the data collector within the vasculature, for example, as indicated by the radiopaque label. In accordance with an embodiment of the present invention, indicia (e.g., a radiopaque marker artifact) are provided on the vasculature map images of a location corresponding to a simultaneously-displayed functional flow image. In preferred embodiments, software tagging provides other visual indicia (e.g. callout marker, box, arrow, or other computing icons) to show the radiopaque marker artifact. In one embodiment, a composite image is displayed showing the vasculature map image with the indicia and the functional flow data image specific to the location of the indicia in the vasculature map image. The vasculature map image and the functional flow image may be simultaneously displayed on a monitor, or each displayed independently on a monitor by minimizing or maximizing the vasculature map image or the functional flow image via a user interface.


The co-registration processor 30 initially buffers external imaging data received via line 34 from the external imaging modality processor 18 in a first portion 36 of image data memory 40. This provides an initial background vasculature map image, which can be updated with time-stamp vasculature map image frames. Thereafter, during the course of a catheterization procedure functional flow data and vasculature map image data received via lines 32 and 34, respectively, is stored within a second portion 38 and a third portion 42, respectively, of the image data memory 40. The individually rendered frames of stored image data are appropriately tagged (e.g., time stamp, sequence number, etc.) to correlate functional flow data frames and corresponding vasculature map (including the radiopaque marker indicia) image data frames. The stored functional flow data frames corresponding to certain vasculature image map frames can be used to track functional flow data across various locations within the vasculature. In certain embodiments, an alert is provided on the vasculature map image that indicates a level of the functional flow data obtained at various locations in the vasculature by the data collector. In addition, additional markers can be placed on the surface of the patient or within the vicinity of the patient within the field of view of the external imaging modality device. The locations of these markers are then used to position the radiopaque label upon the angiographic image in an accurate location.


The co-registration processor 30 renders a co-registration image from the data previously stored within the first portion 36, second portion 38 and third portion 42 of the image data memory 40. By way of example, a functional flow data frame is selected from the second portion 38. The co-registration processor 30 identifies vasculature map image frame within the third portion 42 corresponding to the selected functional flow data frame from the second portion 38. Thereafter, the co-registration processor 30 superimposes the vasculature map image frame from the third portion 42 upon the initial vasculature map image retrieved from the first portion 36. In addition, the functional flow data may be processed to determine clinically relevant measurements from the functional flow data, such as Fractional Flow reserve measurements, Coronary Flow reserve measurements, combined P-V curves, and to display those measurements along with, e.g. pressure and flow readings, in a functional flow image. Thereafter, the co-registered vasculature map image and functional flow image may be simultaneously displayed, along-side one another, upon a graphical display device 50. The co-registered image and functional flow data frames driving the display device 50 are also stored upon a long-term storage device 60 for later review in a session separate from a procedure that acquired the vasculature image data and functional flow data stored in the image data memory 40.


While not shown in FIG. 1, a pullback device may be operably associated with the functional flow device that moves the functional flow 20 from the patient at a controlled/measured manner. Such devices are well known in the art. Incorporation of such devices facilitates calculating a current position of the data collector 22 within a field of view at points in time when the external imaging modality is not actively providing imaging data. For example, if angiography/fluoroscopy is used as an external imaging modality, the pull-back mechanism can be used to track the position of the data collector on the initial background vasculature map image when fluoroscopy is not active.



FIGS. 2-4 illustrate exemplary techniques for mapping functional flow data of the vasculature to vasculature imaging data obtained by an external imaging modality.


Turning to FIG. 2, the external imaging modality processor 18 captures an initial background vasculature map image 200 in a desired projection (patient/vessel orientation) and magnification. By way of example, the initial image 200 is initially captured by the external imaging modality prior to tracking the functional flow device to the region of interest within a patient's vasculature. Although, one may also capture a background vasculature map image during the procedure. The initial image 200 provides shows vessels 210 of the vasculature. Turning to FIG. 3, an exemplary co-registration display 401 (including the correlated vasculature map images and function flow data image) depicts a functional flow image containing functional flow measurements and data relative to the location of the data collector. A vasculature map image 410 is simultaneously displayed along-side the functional flow image 400 on the display 50. The vasculature map image 410 includes a radiopaque label 420, generated from external imaging data rendered by a vasculature image frame, superimposed on a background image rendered from the first portion 36 of the memory 40. The vasculature image frame corresponds to the current location of the data collector 22 within a vessel under observation. Precise matching of the field of view represented in both the background vasculature image and the collected vasculature map image frame during the procedure (i.e., precise projection and magnification of the two images) allows identification of the current position of the data collector corresponding to the displayed functional flow image 400 in the right pane of the co-registered images displayed in FIG. 3.


In some embodiments, image tagging software can be used to automatically identify the location of the radiopaque label, which may appear as a small spot having a darker color than the rest of the image. The image tagging software can automatically locate a box corresponding to the position of the data collector on the vasculature map image, e.g., as shown in FIG. 4. A physician using such this system will be able to locate specific structures of interest and return to those structures with less effort. Accordingly, the procedure will take less time, and the patient and the physician will be exposed to less radiation. After functional flow data is obtained for a region of the vasculature, a physician need only click on a location within those that region on the vasculature map image to pull up the functional flow image corresponding to that location.


In addition to the embodiments described above, the devices, methods, and systems of the invention can be used to catalogue and display overlapping images of intravascular imaging and vascular structure, as is shown in FIG. 5. Again, using image tagging software, or other algorithms, it is possible to display a vasculature map image that co-displays intravascular images. FIG. 5 shows a simulated functional flow image co-located with the location of the data collection on a vasculature map image of pulmonary arteries.


The system also takes heart motion into account when generating/acquiring the external image data of the vasculature (e.g. radiological) and functional flow data. By way of example, by only acquiring the image data for the vasculature map during the peak R-wave of the EKG, heart motion is much less a factor and good overlay correlation exists between the angiogram and fluoroscope fields of view. The peak R-wave is selected because it represents end-diastole, during which the heart has the least amount of motion, and thus, a more consistent condition from which to obtain the external image data. The peak R-wave is also an easy point in the EKG for the system to detect.


With continued reference to FIG. 3 in an exemplary embodiment when the functional flow device 20 begins to collect data, the functional flow data is displayed in tandem with the enhanced vasculature map 410 including both the background vasculature map image and the superimposed vasculature map frame. The enhanced vasculature map image 410 and the functional flow data 400 are displayed close to (e.g., alongside) each other on the display 50, so that the operator can concentrate on the information in the cross-sectional image 400 while virtually simultaneously observing the status of the enhanced radiological image 410.


The simultaneous display of both the composite image with the vasculature map and the functional flow data allows instant awareness of both disease state of a vessel segment and the location of the vessel segment within a patient. Such comprehensive information is not readily discernible in conventional methods for assessing cardiovascular disease. In addition, the functional flow measurements allow one to identify defects and conditions that are not readily visible in vasculature image alone, such as symptoms of microvasculature disease. Neither flythrough nor stacked images alone allows for the simultaneous appreciation of 1) all of the information in a cross-section, 2) a feel for the shape of the vessel and 3) the location of the cross-section along the length of the vessel.


The above-described “co-registration” of a vasculature map image including the radiopaque label and functional flow images/information delivers all three of these items in a presentation that is straight forward to an operator with even average visual and spatial abilities. The co-registration display is presented, by way of example, either on a console display for the functional flow device, or the co-registration display is presented on one or more external imaging modality monitors, either in the room where the procedure is occurring or in a remote location. For example, one monitor over the table in the procedure room allows the attending physician to view the procedure, while at the same time a second consulting physician who has not scrubbed for the case is also able to view the case via a second monitor containing the co-registration display from a separate control room. Control room viewing is also possible without having to wear leaded covering.


With regard to the persistence of the background vasculature map image portion of the enhanced vasculature map image 410 (including the radiopaque label), a single initial image is, by way of example, obtained/generated and stored in the first portion 36 of the memory 40 for a given procedure/patient position. If the field of view changes or the patient's position changes, then an updated background vasculature image is generated and stored in the first portion 36. Alternatively, the background vasculature map image is live or continuously updated. The projection of the roadmap vasculature map image onto the enhanced vasculature image 410 is preferably in an orientation and magnification that best displays the entire vessel to be viewed, taking into account the foreshortening that is present in a tortuous/winding vessel. Alternatively, two background vasculature images (or even two enhanced radiological images 410) can be used/displayed in place of the one image 410.


According to certain aspects, systems and methods of the invention provide for analyzing the functional flow data for one or more parameters and providing an alert on the vasculature map image when the one or more parameters are above the threshold level. Threshold levels may be established to set forth acceptable data ranges that are indicative of stenosis, vessel constriction or other vessel damage. For example, threshold levels may be established for a parameter to categorize the parameter as normal or abnormal. In addition, a threshold level may be established for an intermediate range between normal and abnormal. In one embodiment, parameters for function flow data include levels for Coronary flow reserve, Fractional flow reserve, pressure-volume (P-V) curves/loops, or combinations thereof.


Coronary flow reserve is defined as the ratio of maximal coronary flow with hyperemia to normal flow. Coronary flow reserve signifies the ability of the myocardium to increase blood flow in response to maximal exercise. A ratio at or above 2 is considered normal. Abnormal CFR (a ratio below 2) indicates stenosis, abnormal constriction of microarteries, or both. Coronary flow reserve measures the velocity of the flow. Fractional flow reserve measure pressure differences across a portion of a vessel to determine whether a level of constriction or stenosis of the vessel will impede oxygen delivery to the heart muscle. Specifically, Fractional flow reserve is a ratio of a level of pressure distal to a portion of a vessel under examination to a level of pressure proximal to a portion of a vessel under examination. Often a cut-off point is 0.75 to 0.80 has been used, in which high values indicate a non-significant stenosis or constriction and lower values indicate a significant stenosis and lesion.


P-V loops provide a framework for understanding cardiac mechanics. Such loops can be generated by real time measurement of pressure and volume within the left ventricle. Several physiologically relevant hemodynamic parameters such as stroke volume, cardiac output, ejection fraction, myocardial contractility, etc. can be determined from these loops. To generate a P-V loop for the left ventricle, the LV pressure is plotted against LV volume at multiple time points during a single cardiac cycle. The presence of a stenosis or constriction can alter the curve/shape of P-V loop from a normal P-V loop.


It has been shown that distal pressure and velocity measurements, particularly regarding the pressure drop-velocity relationship such as Fractional Flow reserve (FFR), Coronary flow reserve (CFR) and combined P-V curves, reveal information about the stenosis severity. For example, in use, the functional flow device may be advanced to a location on the distal side of the stenosis. The pressure and flow velocity may then be measured at a first flow state. Then, the flow rate may be significantly increased, for example by the use of drugs such as adenosine, and the pressure and flow measured in this second, hyperemic, flow state. The pressure and flow relationships at these two flow states are then compared to assess the severity of the stenosis and provide improved guidance for any coronary interventions. The ability to take the pressure and flow measurements at the same location and same time with a combined pressure/flow guidewire, improves the accuracy of these pressure-velocity loops and therefore improves the accuracy of the diagnostic information.


Coronary flow reserve, Fractional flow reserve, and P-V loops may require measurements taken at different locations in the artery. In order to provide measurements for these parameters, systems and methods of the invention may assess pressure and flow at a first location of the data collector against a second location of the data collector within the vasculature. For example, a first location that is distal to a segment of a vessel under examination and a second location that is proximal to that segment of a vessel. The obtained measurements across the two locations are then assessed against the one or more threshold levels, and an alert is provided on the vasculature image map when the one or more parameters are at or beyond a threshold level. The alert, for example, may be indicated for a single location of the data collector on the vasculature map image corresponding to one or more parameters, or may be indicated for several locations of the data collector corresponding to a plurality of parameters, or may be indicated over one or more location points of the data collector that correspond to a single parameter on the vasculature image map.


In some embodiments, the alert is a color coded indicator, a pulsating indicator, a color map of the one or more parameters, a callout marker, or a combination thereof. If functional flow data corresponding to one or more locations on the vasculature image map is above or at a threshold level, an alert is provided at those one or more locations. Any combination of alerts used to indicate areas of interest on the vasculature map image are contemplated herein. In one example, the alert is a color-coded callout marker. In another example, the alert is a color map with a call-out marker. FIGS. 6-9B indicate use of alerts according to certain embodiments.


As shown in FIG. 6, an arrow indicating the location of the data collector and lines visually linking the functional flow image to that location are given a different color if one or more parameters from the functional flow data at that location are at or above a threshold level for those one or more parameters. For example, the arrow and linking lines in FIG. 6 may be green if the functional flow data indicates, for example, that there is no abnormal vessel constriction or stenosis at that particular location in the vasculature. Alternatively, red may be used to indicate abnormal vessel constriction or stenosis at a particular location in the vasculature. In another embodiment, instead of or in combination with the color used to indicate a level of constriction or stenosis, the arrow and/or linking lines may pulsate to indicate a level of constriction or stenosis. In other examples, the functional flow image itself may pulsate to indicate a measurement at or beyond a threshold level.



FIG. 7 shows a color map of the vasculature image map for a parameter. As show in FIG. 7, region of the vasculature are labeled A, B, and C. Those regions indicate different colors of the vasculature based on measurements of functional flow data corresponding to those regions. For the color map, regions A may be green to indicate that those regions have normal functional flow data measurements; region B may be yellow to indicate that those regions have intermediate functional flow data measurements (borderline between healthy and abnormal), and regions C may be red to indicate that those regions have abnormal flow data measurements. As a result, a physician, using systems of the invention, need only look at the vasculature map image to quickly pinpoint regions of interests in the vasculature. In addition, the physician need only click on a location within the color map region of the vasculature map to pull up functional flow image data corresponding to that location. For example, if the physician clicked on point X, FIG. 8 would appear that simultaneously shows the functional flow image corresponding to point X.



FIGS. 9A-9B show use of callout markers on the vasculature image map to signify areas of interest of the vasculature corresponding to the functional flow data. As discussed, the area of interest may be a location where a parameter of the functional flow data at that location is at or above a threshold level. Upon clicking one of the call-out markers, the functional flow image associated with that location of the vasculature will appear, such as in FIG. 9B. In certain embodiments, one may click on multiple callout markers during a session to compare functional flow images corresponding to the callout markers.


Functional flow devices suitable for use in methods and systems of the invention may be a guidewire or a catheter. Preferably, the functional flow device is a guidewire sized to fit within the interior of a microvascular vessel. Exemplary guidewires include FloWire Doppler Guidewire and the ComboWire XT Guidewire by Volcano Corporation.



FIG. 10 depicts a guidewire 5 suitable for use in methods and systems of the invention. The guidewire 5 includes a flexible elongate member 100 having a proximal portion 102 and a distal portion 104. The guidewire 5 may have an average diameter of 0.018″ and less. The flexible elongate member 100 typically includes an elongate shaft 116 and a coil segment 112. The flexible elongate shaft 116 can be formed of any suitable material such as stainless steel, nickel and titanium alloy (Nitinol, polyimide, polyetheretherketone or other metallic or polymeric materials and having a suitable wall thickness, such as, e.g., 0.001″ to 0.002″. This flexible elongate shaft is conventionally called a hypotube. In one embodiment, the hypotube may have a length of 130 to 170 cm. The guidewire further includes a core member 150 disposed within a lumen of the elongate member 100. The core member 150 extends from the proximal portion to the distal portion of the flexible elongate member 100 to provide the desired torsional properties to facilitate steering of the guidewire in the vessel and to provide strength to the guidewire and prevent kinking. The core member can be formed of a suitable material such as stainless steel, nickel and titanium alloy (Nitinol), polyimide, polyetheretherketone, or other metallic or polymeric materials.


A proximal end of the core member 150 may be connected to a handle. The proximal end of core member 150 can be removeably coupled to a connector housing 106. In addition to receiving the proximal end of the core member 150, the connector housing 106 may also removeably connect to and receive one or more electrical connection wires (not shown) that run the length of the elongate body 100 and connect to one or more sensors on the distal portion 102. This removable connection allows one to disconnect the guidewire from the connector housing 106 when placing a catheter over the guidewire and reconnect the guidewire thereafter to prove electrical communication to the sensors. The connector housing 106 may include one or more electrical connections that mate with the electrical conductor wires. The connector housing 106 may be connected to an output connector 72 via a cable 108. The output connector 72 may be the proximal connector 24 shown in FIG. 1, or coupled to the proximal connector 24 shown in FIG. 1. The proximal connector 24 transmits signals from one or more sensors to the functional flow data processor 26 of FIG. 1.


A sensor housing 120 may be positioned on the elongate member 100. The sensor housing 120 includes a housing body that defines a lumen. One or more cavities may be shaped into the walls of the sensor housing to form windows for sensors disposed or mounted therein. The sensor housing is preferably positioned between the coil segment 112 and the distal tip 110. The sensor housing 120 contains one or more data collectors configured to receive and transmit functional flow data to functional flow processor 26.


Data collectors suitable for use in methods and devices of the invention include, for example, a pressure sensor, flow sensor, or combination thereof. The data collectors are co-located with a radiopaque label so that the location of the functional flow data can be determined.


A pressure sensor allows one to obtain pressure measurements within a body lumen. A particular benefit of pressure sensors is that pressure sensors allow one to measure of FFR in vessel. FFR is a comparison of the pressure within a vessel at positions prior to the stenosis and after the stenosis. The level of FFR determines the significance of the stenosis, which allows physicians to more accurately identify clinically relevant stenosis. For example, an FFR measurement above 0.80 indicates normal coronary blood flow and a non-significant stenosis. Another benefit is that a physician can measure the pressure before and after an intraluminal intervention procedure to determine the impact of the procedure.


A pressure sensor can be mounted on the distal portion of a flexible elongate member. In certain embodiments, the pressure sensor is positioned distal to the compressible and bendable coil segment of the elongate member. This allows the pressure sensor to move along with the along coil segment as bended and away from the longitudinal axis. The pressure sensor can be formed of a crystal semiconductor material having a recess therein and forming a diaphragm bordered by a rim. A reinforcing member is bonded to the crystal and reinforces the rim of the crystal and has a cavity therein underlying the diaphragm and exposed to the diaphragm. A resistor having opposite ends is carried by the crystal and has a portion thereof overlying a portion of the diaphragm. Electrical conductor wires can be connected to opposite ends of the resistor and extend within the flexible elongate member to the proximal portion of the flexible elongate member. Additional details of suitable pressure sensors that may be used with devices of the invention are described in U.S. Pat. No. 6,106,476. U.S. Pat. No. 6,106,476 also describes suitable methods for mounting the pressure sensor 104 within a sensor housing.


A flow sensor can be used to measure blood flow velocity within the vessel, which can be used to assess coronary flow reserve (CFR). The flow sensor can be, for example, an ultrasound transducer, a Doppler flow sensor or any other suitable flow sensor, disposed at or in close proximity to the distal tip of the guidewire. The ultrasound transducer may be any suitable transducer, and may be mounted in the distal end using any conventional method, including the manner described in U.S. Pat. Nos. 5,125,137, 6,551,250 and 5,873,835.


External imaging modality devices for use in methods and devices of the invention include, for example, X-ray angiography imaging, computed tomography imaging, and magnetic resonance imaging devices. Preferably, the imaging modality is computed tomography which does not require the use of a contrast, which may not enter the small vessels of the microvasculature or stenosis vessels in adequate amounts for proper imaging.


A system of the invention may be implemented in a number of formats. An embodiment of a system 300 of the invention is shown in FIG. 11. The core of the system 300 is a computer 360 or other computational arrangement (see FIG. 12) comprising a processor 365 and memory 367. The memory has instructions which when executed cause the processor to receive imaging data of vasculature of a subject collected with an image collector co-located with a radiopaque label. The functional flow data of vasculature will typically originate from a data collector 320, which is in electronic and/or mechanical communication with a functional flow device 325. The memory additionally has instructions which when executed cause the processor to receive an image of the subject including the radiopaque label. The image of the subject will typically be an x-ray image, such as produced during an angiogram, CT scan, MRI scan. The image of the subject will typically originate in an external imaging device 340, which is in electronic and/or mechanical communication with a radiological source 343 and a radiological image collector 347 such as a flat panel detector. Having collected the images, the processor then processes the image, and outputs an image of the subject showing the location of the data collector 320, as well as an image of the vasculature of a subject. The images are typically output to a display 380 to be viewed by a physician or technician. In some embodiments a displayed image will simultaneously include both the functional flow image and the image of the vasculature, for example as shown in FIGS. 3-5.


In advanced embodiments, system 300 may comprise an imaging engine 370 which has advanced image processing features, such as image tagging, that allow the system 300 to more efficiently process and display combined functional flow and vasculature map images. The imaging engine 370 may automatically highlight or otherwise denote areas of interest in the vasculature. The imaging engine 370 may also produce 3D renderings of the vasculature map images. In some embodiments, the imaging engine 370 may additionally include data acquisition functionalities (DAQ) 375, which allow the imaging engine 370 to receive the imaging data directly from the functional flow device 325 or collector 347 to be processed into images for display.


Other advanced embodiments use the I/O functionalities 362 of computer 360 to control the intravascular imaging 320 or the external imaging modality 340. In these embodiments, computer 360 may cause the data collector of the functional flow device 325 to travel to a specific location, e.g., if the functional flow device 325 is a pull-back type. The computer 360 may also cause source 343 to irradiate the field to obtain a refreshed image of the vasculature, or to clear collector 347 of the most recent image. While not shown here, it is also possible that computer 360 may control a manipulator, e.g., a robotic manipulator, connected to functional flow device 325 to improve the placement of the functional flow device 325.


A system 400 of the invention may also be implemented across a number of independent platforms which communicate via a network 409, as shown in FIG. 12. Methods of the invention can be performed using software, hardware, firmware, hardwiring, or combinations of any of these. Features implementing functions can also be physically located at various positions, including being distributed such that portions of functions are implemented at different physical locations (e.g., imaging apparatus in one room and host workstation in another, or in separate buildings, for example, with wireless or wired connections).


As shown in FIG. 12, the functional flow data collector 320 and the external imaging modality 340 are key for obtaining the data, however the actual implementation of the steps for data collection, co-registration of the data, storage and data output, can be performed by multiple processors working in communication via the network 409, for example a local area network, a wireless network, or the internet. The components of system 400 may also be physically separated. For example, terminal 467 and display 380 may not be geographically located with the functional flow data collector 320 and the external imaging modality 340.


As shown in FIG. 12, imaging engine 859 communicates with host workstation 433 as well as optionally server (not shown) over network 409. In some embodiments, an operator uses host workstation 433, computer 360, or terminal 467 to control system 400 or to receive images and functional flow data. An image may be displayed using an I/O 362, 437, or 471, which may include a monitor. Any I/O may include a monitor, keyboard, mouse or touch screen to communicate with any of processor 365, 441, or 475, for example, to cause data to be stored in any tangible, nontransitory memory 367, 445, or 479. Server generally includes an interface module to communicate over network 409 or write data to data file. Input from a user is received by a processor in an electronic device such as, for example, host workstation 433, terminal 467, or computer 360. In certain embodiments, host workstation 433 and imaging engine 855 are included in a bedside console unit to operate system 400.


In some embodiments, the system may render three dimensional imaging of the vasculature or the intravascular images. An electronic apparatus within the system (e.g., PC, dedicated hardware, or firmware) such as the host workstation 433 stores the three dimensional image in a tangible, non-transitory memory and renders an image of the 3D tissues on the display 380. In some embodiments, the 3D images will be coded, as previously-discussed, for faster viewing. In certain embodiments, systems of the invention render a GUI with elements or controls to allow an operator to interact with three dimensional data set as a three dimensional view. In other embodiments an operator may select points from within one of the images or the three dimensional data set by choosing start and stop points while a dynamic progress view is displayed in display. In other embodiments, a user may cause a functional flow device to be relocated to a new position in the body by interacting with the vasculature map image.


In some embodiments, a user interacts with a visual interface and puts in parameters or makes a selection. Input from a user (e.g., parameters or a selection) are received by a processor in an electronic device such as, for example, host workstation 433, terminal 467, or computer 360. The selection can be rendered into a visible display. In some embodiments, an operator uses host workstation 433, computer 360, or terminal 467 to control system 400 or to receive images. An image may be displayed using an I/O 362, 437, or 471, which may include a monitor. Any I/O may include a keyboard, mouse or touch screen to communicate with any of processor 365, 441, or 475, for example, to cause data to be stored in any tangible, nontransitory memory 367, 445, or 479. Server generally includes an interface module to effectuate communication over network or write data to data file. Methods of the invention can be performed using software, hardware, firmware, hardwiring, or combinations of any of these. Features implementing functions can also be physically located at various positions, including being distributed such that portions of functions are implemented at different physical locations (e.g., imaging apparatus in one room and host workstation in another, or in separate buildings, for example, with wireless or wired connections). In certain embodiments, host workstation 433 and imaging engine 855 are included in a bedside console unit to operate system 400.


Processors suitable for the execution of computer program include, by way of example, both general and special purpose microprocessors, and any one or more processor of any kind of digital computer. Generally, a processor will receive instructions and data from a read-only memory or a random access memory or both. The essential elements of computer are a processor for executing instructions and one or more memory devices for storing instructions and data. Generally, a computer will also include, or be operatively coupled to receive data from or transfer data to, or both, one or more mass storage devices for storing data, e.g., magnetic, magneto-optical disks, or optical disks. Information carriers suitable for embodying computer program instructions and data include all forms of non-volatile memory, including by way of example semiconductor memory devices, (e.g., EPROM, EEPROM, NAND-based flash memory, solid state drive (SSD), and other flash memory devices); magnetic disks, (e.g., internal hard disks or removable disks); magneto-optical disks; and optical disks (e.g., CD and DVD disks). The processor and the memory can be supplemented by, or incorporated in, special purpose logic circuitry.


To provide for interaction with a user, the subject matter described herein can be implemented on a computer having an I/O device, e.g., a CRT, LCD, LED, or projection device for displaying information to the user and an input or output device such as a keyboard and a pointing device, (e.g., a mouse or a trackball), by which the user can provide input to the computer. Other kinds of devices can be used to provide for interaction with a user as well. For example, feedback provided to the user can be any form of sensory feedback, (e.g., visual feedback, auditory feedback, or tactile feedback), and input from the user can be received in any form, including acoustic, speech, or tactile input.


The subject matter described herein can be implemented in a computing system that includes a back-end component (e.g., a data server), a middleware component (e.g., an application server), or a front-end component (e.g., a client computer 360 having a graphical user interface or a web browser through which a user can interact with an implementation of the subject matter described herein), or any combination of such back-end, middleware, and front-end components. The components of the system can be interconnected through network 409 by any form or medium of digital data communication, e.g., a communication network. Examples of communication networks include cell networks (3G, 4G), a local area network (LAN), and a wide area network (WAN), e.g., the Internet.


The subject matter described herein can be implemented as one or more computer program products, such as one or more computer programs tangibly embodied in an information carrier (e.g., in a non-transitory computer-readable medium) for execution by, or to control the operation of, data processing apparatus (e.g., a programmable processor, a computer, or multiple computers). A computer program (also known as a program, software, software application, app, macro, or code) can be written in any form of programming language, including compiled or interpreted languages (e.g., C, C++, Perl), and it can be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a computing environment. Systems and methods of the invention can include programming language known in the art, including, without limitation, C, C++, Perl, Java, ActiveX, HTML5, Visual Basic, or JavaScript.


A computer program does not necessarily correspond to a file. A program can be stored in a portion of file that holds other programs or data, in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files that store one or more modules, sub-programs, or portions of code). A computer program can be deployed to be executed on one computer or on multiple computers at one site or distributed across multiple sites and interconnected by a communication network.


A file can be a digital file, for example, stored on a hard drive, SSD, CD, or other tangible, non-transitory medium. A file can be sent from one device to another over network 409 (e.g., as packets being sent from a server to a client, for example, through a Network Interface Card, modem, wireless card, or similar).


Writing a file according to the invention involves transforming a tangible, non-transitory computer-readable medium, for example, by adding, removing, or rearranging particles (e.g., with a net charge or dipole moment) into patterns of magnetization by read/write heads, the patterns then representing new collocations of information desired by, and useful to, the user. In some embodiments, writing involves a physical transformation of material in tangible, non-transitory computer readable media with certain properties so that optical read/write devices can then read the new and useful collocation of information (e.g., burning a CD-ROM). In some embodiments, writing a file includes using flash memory such as NAND flash memory and storing information in an array of memory cells include floating-gate transistors. Methods of writing a file are well-known in the art and, for example, can be invoked automatically by a program or by a save command from software or a write command from a programming language.


In certain embodiments, display 380 is rendered within a computer operating system environment, such as Windows, Mac OS, or Linux or within a display or GUI of a specialized system. Display 380 can include any standard controls associated with a display (e.g., within a windowing environment) including minimize and close buttons, scroll bars, menus, and window resizing controls. Elements of display 380 can be provided by an operating system, windows environment, application programming interface (API), web browser, program, or combination thereof (for example, in some embodiments a computer includes an operating system in which an independent program such as a web browser runs and the independent program supplies one or more of an API to render elements of a GUI). Display 380 can further include any controls or information related to viewing images (e.g., zoom, color controls, brightness/contrast) or handling files comprising three-dimensional image data (e.g., open, save, close, select, cut, delete, etc.). Further, display 380 can include controls (e.g., buttons, sliders, tabs, switches) related to operating a three dimensional image capture system (e.g., go, stop, pause, power up, power down).


In certain embodiments, display 380 includes controls related to three dimensional imaging systems that are operable with different imaging modalities. For example, display 380 may include start, stop, zoom, save, etc., buttons, and be rendered by a computer program that interoperates with functional flow device and external imaging modalities. Thus display 380 can display an image derived from a three-dimensional data set with or without regard to the imaging mode of the system.


INCORPORATION BY REFERENCE

References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made throughout this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes.


EQUIVALENTS

Various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including references to the scientific and patent literature cited herein. The subject matter herein contains important information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof

Claims
  • 1. A system for assessing vasculature of a subject, the system comprising: one or more processors configured for communication with an intravascular device comprising a sensor configured to obtain functional flow data while positioned within the vasculature, wherein the one or more processors are configured to: receive the functional flow data obtained by the sensor at a plurality of locations of the vasculature, wherein the function flow data comprises: values specific to a first location of the plurality of locations and obtained by the sensor at the first location; andvalues specific to a second location of the plurality of locations and obtained by the sensor at the second location;receive an external image of the vasculature;output, to a monitor in communication with the one or more processors, a screen display that includes: the external image; anda first marker indicating the first location in the external image; anda second marker indicating the second location in the external image;receive, from a user interface in communication with the one or more processors, different user inputs selecting the first marker and the second marker, respectively, during a same session to perform a comparison between functional flow data at the first location and at the second location; andcause the monitor to update the screen display in response to the different user inputs such that the updated screen display comprises: the external image;a user interface (UI) element comprising at least one of a plot or a numerical value, based on the values of the functional flow data specific to the first location when the first marker is selected or the values of the functional flow data specific to the second location when the second marker is selected; andat least one indicator visually linking the UI element to the first location in the external image when the first marker is selected or the second location in the external image when the second marker is selected,wherein the UI element is overlaid on the external image such that the first location in the external image remains uncovered when the first marker is selected or the second location in the external image remains uncovered when the second marker is selected.
  • 2. The system of claim 1, wherein the intravascular device comprises a guidewire,wherein the sensor comprises a pressure sensor, andwherein the functional flow data obtained by the sensor comprises pressure data.
  • 3. The system of claim 2, wherein the intravascular device further comprises a flow sensor, andwherein the functional flow data obtained by the sensor comprises the pressure data and flow velocity data.
  • 4. The system of claim 1, wherein the intravascular device comprises a guidewire,wherein the sensor comprises a flow sensor, andwherein the functional flow data obtained by the sensor comprises flow velocity data.
  • 5. The system of claim 1, wherein the numerical value comprises at least one of a fractional flow reserve (FFR), or a coronary flow reserve (CFR).
  • 6. The system of claim 1, wherein the external image comprises a roadmap image of the vasculature.
  • 7. The system of claim 1, wherein the one or more processors are further configured to: receive a fluoroscopic image representative of the vasculature and the intravascular device;identify a location of the intravascular device; andco-register the functional flow data obtained by the sensor with the location of the intravascular device.
  • 8. The system of claim 7, wherein the one or more processors are further configured to: process the co-registered functional flow data obtained by the sensor to identify a subset of the plurality of locations at which the numerical value meets or exceeds a threshold level.
  • 9. The system of claim 8, wherein the screen display comprises a plurality of markers comprising the first marker and the second marker, wherein the plurality of markers indicate the subset of the plurality of locations at which the numerical value meets or exceeds the threshold level.
  • 10. The system of claim 9, wherein the plurality of markers indicate only locations where the numerical value meet or exceeds the threshold level.
  • 11. The system of claim 8, wherein the one or more processors are configured to identify the subset of the plurality of locations based on a comparison of the numerical value to the threshold level.
  • 12. The system of claim 1, wherein the one or more processors are configured to receive the different user inputs only after the one or more processors receive the functional flow data obtained by the sensor and the external image.
  • 13. The system of claim 1, wherein the UI element comprises: the plot of the functional flow data; anda further plot associated with the functional flow data at the first location when the first marker is selected or at the second location when the second marker is selected.
  • 14. The system of claim 1, wherein the at least one indicator is overlaid on the external image in the screen display.
  • 15. The system of claim 1, wherein the UI element further comprises a border outlining a perimeter of the UI element, and wherein the at least one of the plot or the numerical value is positioned within the border.
  • 16. The system of claim 15, wherein the at least one indicator extends from the first location on the external image to the border of the UI element when the first marker is selected and from the second location on the external image to the border of the UI element when the second marker is selected.
  • 17. The system of claim 16, wherein the at least one indicator comprises a plurality of indicators, andwherein the plurality of indicators extends from a same position on the external image to different positions on the border of the UI element.
  • 18. The system of claim 17, wherein the different positions comprise opposite corners on the border of the UI element.
  • 19. The system of claim 1, wherein the UI element is overlaid on a first portion of the external image when the first marker is selected and on a different, second portion of the external image when the second marker is selected.
  • 20. The system of claim 19, wherein the at least one indicator extends in different directions from the vasculature to the UI element when the first marker is selected and when the second marker is selected.
RELATED APPLICATION

The present application is a continuation of U.S. application Ser. No. 14/204,277, filed Mar. 11, 2014, now U.S. Pat. No. 10,638,939, which claims the benefit of and priority to U.S. provisional patent application Ser. No. 61/776,863, filed Mar. 12, 2013, the content of which is incorporated by reference herein in its entirety.

US Referenced Citations (909)
Number Name Date Kind
3301258 Werner Jan 1967 A
3617880 Cormack et al. Nov 1971 A
3789841 Antoshkiw Feb 1974 A
3841308 Tate Oct 1974 A
4140364 Yamashita et al. Feb 1979 A
4274423 Mizuno et al. Jun 1981 A
4344438 Schultz Aug 1982 A
4398791 Dorsey Aug 1983 A
4432370 Hughes et al. Feb 1984 A
4552554 Gould et al. Nov 1985 A
4577543 Wilson Mar 1986 A
4676980 Segal et al. Jun 1987 A
4682895 Costello Jul 1987 A
4733665 Palmaz Mar 1988 A
4744619 Cameron May 1988 A
4762129 Bonze Aug 1988 A
4766386 Oliver et al. Aug 1988 A
4771774 Simpson et al. Sep 1988 A
4794931 Yock Jan 1989 A
4800886 Nestor Jan 1989 A
4803639 Steele et al. Feb 1989 A
4816567 Cabilly et al. Mar 1989 A
4819740 Warrington Apr 1989 A
4821731 Martinelli et al. Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4830023 de Toledo et al. May 1989 A
4834093 Littleford et al. May 1989 A
4841977 Griffith et al. Jun 1989 A
4864578 Proffitt et al. Sep 1989 A
4873690 Adams Oct 1989 A
4877314 Kanamori Oct 1989 A
4887606 Yock et al. Dec 1989 A
4917085 Smith Apr 1990 A
4917097 Proudian, deceased et al. Apr 1990 A
4928693 Goodin et al. May 1990 A
4932413 Shockey et al. Jun 1990 A
4932419 de Toledo Jun 1990 A
4948229 Soref Aug 1990 A
4951677 Crowley et al. Aug 1990 A
4969742 Falk et al. Nov 1990 A
4987412 Vaitekunas et al. Jan 1991 A
4993412 Murphy-Chutorian Feb 1991 A
4998972 Chin et al. Mar 1991 A
5000185 Yock Mar 1991 A
5024234 Leary et al. Jun 1991 A
5025445 Anderson et al. Jun 1991 A
5032123 Katz et al. Jul 1991 A
5037169 Chun Aug 1991 A
5039193 Snow et al. Aug 1991 A
5040548 Yock Aug 1991 A
5041108 Fox et al. Aug 1991 A
5054492 Scribner et al. Oct 1991 A
5065010 Knute Nov 1991 A
5065769 de Toledo Nov 1991 A
5085221 Ingebrigtsen et al. Feb 1992 A
5095911 Pomeranz Mar 1992 A
5100424 Jang et al. Mar 1992 A
5120308 Hess Jun 1992 A
5125137 Corl et al. Jun 1992 A
5135486 Eberle et al. Aug 1992 A
5135516 Sahatjian et al. Aug 1992 A
5148809 Biegeleisen-Knight Sep 1992 A
5155439 Holmbo et al. Oct 1992 A
5158548 Lau et al. Oct 1992 A
5163445 Christian et al. Nov 1992 A
5167233 Eberle et al. Dec 1992 A
5174295 Christian et al. Dec 1992 A
5176141 Bom et al. Jan 1993 A
5176674 Hofmann Jan 1993 A
5178159 Christian Jan 1993 A
5183048 Eberle Feb 1993 A
5188632 Goldenberg Feb 1993 A
5201316 Pomeranz et al. Apr 1993 A
5202745 Sorin et al. Apr 1993 A
5203779 Muller et al. Apr 1993 A
5220922 Barany Jun 1993 A
5224953 Morgentaler Jul 1993 A
5226421 Frisbie et al. Jul 1993 A
5240003 Lancee et al. Aug 1993 A
5240437 Christian Aug 1993 A
5242460 Klein et al. Sep 1993 A
5243988 Sieben et al. Sep 1993 A
5257974 Cox Nov 1993 A
5266302 Peyman et al. Nov 1993 A
5267954 Nita Dec 1993 A
5301001 Murphy et al. Apr 1994 A
5312425 Evans et al. May 1994 A
5313949 Yock May 1994 A
5313957 Little May 1994 A
5319492 Dorn et al. Jun 1994 A
5321501 Swanson et al. Jun 1994 A
5325198 Hartley et al. Jun 1994 A
5336178 Kaplan et al. Aug 1994 A
5346689 Peyman et al. Sep 1994 A
5348017 Thornton et al. Sep 1994 A
5348481 Ortiz Sep 1994 A
5353798 Sieben Oct 1994 A
5358409 Obara Oct 1994 A
5358478 Thompson et al. Oct 1994 A
5368037 Eberle et al. Nov 1994 A
5373845 Gardineer et al. Dec 1994 A
5373849 Maroney et al. Dec 1994 A
5375602 Lancee et al. Dec 1994 A
5377682 Ueno et al. Jan 1995 A
5383853 Jung et al. Jan 1995 A
5387193 Miraki Feb 1995 A
5396328 Jestel et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5405377 Cragg Apr 1995 A
5411016 Kume et al. May 1995 A
5419777 Hofling May 1995 A
5421338 Crowley et al. Jun 1995 A
5423806 Dale et al. Jun 1995 A
5427118 Nita et al. Jun 1995 A
5431673 Summers et al. Jul 1995 A
5436759 Dijaili et al. Jul 1995 A
5439139 Brovelli Aug 1995 A
5443457 Ginn et al. Aug 1995 A
5453575 O'Donnell et al. Sep 1995 A
5456693 Conston et al. Oct 1995 A
5459570 Swanson et al. Oct 1995 A
5480388 Zadini et al. Jan 1996 A
5485845 Verdonk et al. Jan 1996 A
5492125 Kim et al. Feb 1996 A
5496997 Pope Mar 1996 A
5507761 Duer Apr 1996 A
5512044 Duer Apr 1996 A
5514128 Hillsman et al. May 1996 A
5529674 Hedgcoth Jun 1996 A
5541730 Chaney Jul 1996 A
5546717 Penczak et al. Aug 1996 A
5546948 Hamm et al. Aug 1996 A
5565332 Hoogenboom et al. Oct 1996 A
5573520 Schwartz et al. Nov 1996 A
5581638 Givens et al. Dec 1996 A
5586054 Jensen et al. Dec 1996 A
5592939 Martinelli Jan 1997 A
5596079 Smith et al. Jan 1997 A
5598844 Diaz et al. Feb 1997 A
5609606 O'Boyle Mar 1997 A
5630806 Inagaki et al. May 1997 A
5651366 Liang et al. Jul 1997 A
5660180 Malinowski et al. Aug 1997 A
5667499 Welch et al. Sep 1997 A
5667521 Keown Sep 1997 A
5672877 Liebig et al. Sep 1997 A
5674232 Halliburton Oct 1997 A
5693015 Walker et al. Dec 1997 A
5713848 Dubrul et al. Feb 1998 A
5745634 Garrett et al. Apr 1998 A
5771895 Slager Jun 1998 A
5779731 Leavitt Jul 1998 A
5780958 Strugach et al. Jul 1998 A
5798521 Froggatt Aug 1998 A
5800450 Lary et al. Sep 1998 A
5803083 Buck et al. Sep 1998 A
5814061 Osborne et al. Sep 1998 A
5817025 Alekseev et al. Oct 1998 A
5820594 Fontirroche et al. Oct 1998 A
5824520 Mulligan-Kehoe Oct 1998 A
5827313 Ream Oct 1998 A
5830222 Makower Nov 1998 A
5848121 Gupta et al. Dec 1998 A
5851464 Davila et al. Dec 1998 A
5857974 Eberle et al. Jan 1999 A
5872829 Wischmann et al. Feb 1999 A
5873835 Hastings et al. Feb 1999 A
5882722 Kydd Mar 1999 A
5912764 Togino Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5921931 O'Donnell et al. Jul 1999 A
5925055 Adrian et al. Jul 1999 A
5949929 Hamm Sep 1999 A
5951586 Berg et al. Sep 1999 A
5974521 Akerib Oct 1999 A
5976120 Chow et al. Nov 1999 A
5978391 Das et al. Nov 1999 A
5997523 Jang Dec 1999 A
6021240 Murphy et al. Feb 2000 A
6022319 Willard et al. Feb 2000 A
6031071 Mandeville et al. Feb 2000 A
6036889 Kydd Mar 2000 A
6043883 Leckel et al. Mar 2000 A
6050949 White et al. Apr 2000 A
6059738 Stoltze et al. May 2000 A
6068638 Makower May 2000 A
6074362 Jang et al. Jun 2000 A
6078831 Belef et al. Jun 2000 A
6080109 Baker et al. Jun 2000 A
6091496 Hill Jul 2000 A
6094591 Foltz et al. Jul 2000 A
6095976 Nachtomy et al. Aug 2000 A
6097755 Guenther, Jr. et al. Aug 2000 A
6099471 Torp et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6102938 Evans et al. Aug 2000 A
6106476 Corl Aug 2000 A
6120445 Grunwald Sep 2000 A
6123673 Eberle et al. Sep 2000 A
6134003 Tearney et al. Oct 2000 A
6135893 Probert Oct 2000 A
6139510 Palermo Oct 2000 A
6141089 Thoma et al. Oct 2000 A
6146328 Chiao et al. Nov 2000 A
6148095 Prause et al. Nov 2000 A
6151433 Dower et al. Nov 2000 A
6152877 Masters Nov 2000 A
6152878 Nachtomy et al. Nov 2000 A
6159225 Makower Dec 2000 A
6165127 Crowley Dec 2000 A
6176842 Tachibana et al. Jan 2001 B1
6179809 Khairkhahan et al. Jan 2001 B1
6186949 Hatfield et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6200266 Shokrollahi et al. Mar 2001 B1
6200268 Vince et al. Mar 2001 B1
6203537 Adrian Mar 2001 B1
6208415 De Boer et al. Mar 2001 B1
6210332 Chiao et al. Apr 2001 B1
6210339 Kiepen et al. Apr 2001 B1
6212308 Donald Apr 2001 B1
6231518 Grabek et al. May 2001 B1
6245066 Morgan et al. Jun 2001 B1
6249076 Madden et al. Jun 2001 B1
6254543 Grunwald et al. Jul 2001 B1
6256090 Chen et al. Jul 2001 B1
6258052 Milo Jul 2001 B1
6261246 Pantages et al. Jul 2001 B1
6275628 Jones et al. Aug 2001 B1
6283921 Nix et al. Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6295308 Zah Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6312384 Chiao Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328696 Fraser Dec 2001 B1
6343168 Murphy et al. Jan 2002 B1
6343178 Burns et al. Jan 2002 B1
6350240 Song et al. Feb 2002 B1
6364841 White et al. Apr 2002 B1
6366722 Murphy et al. Apr 2002 B1
6367984 Stephenson et al. Apr 2002 B1
6373970 Dong et al. Apr 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6375618 Chiao et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6376830 Froggatt et al. Apr 2002 B1
6379352 Reynolds et al. Apr 2002 B1
6381350 Klingensmith et al. Apr 2002 B1
6387124 Buscemi et al. May 2002 B1
6396976 Little et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6417948 Chowdhury et al. Jul 2002 B1
6419644 White et al. Jul 2002 B1
6421164 Tearney et al. Jul 2002 B2
6423012 Kato et al. Jul 2002 B1
6426796 Pulliam et al. Jul 2002 B1
6428041 Wohllebe et al. Aug 2002 B1
6428498 Uflacker Aug 2002 B2
6429421 Meller et al. Aug 2002 B1
6440077 Jung et al. Aug 2002 B1
6443894 Sumanaweera Sep 2002 B1
6443903 White et al. Sep 2002 B1
6450964 Webler Sep 2002 B1
6457365 Stephens et al. Oct 2002 B1
6459844 Pan Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6475149 Sumanaweera Nov 2002 B1
6480285 Hill Nov 2002 B1
6491631 Chiao et al. Dec 2002 B2
6491636 Chenal et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6504286 Porat et al. Jan 2003 B1
6508824 Flaherty et al. Jan 2003 B1
6514237 Maseda Feb 2003 B1
6520269 Geiger et al. Feb 2003 B2
6520677 Iizuka Feb 2003 B2
6535764 Imran et al. Mar 2003 B2
6538778 Leckel et al. Mar 2003 B1
6544217 Gulachenski Apr 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6545760 Froggatt et al. Apr 2003 B1
6546272 MacKinnon et al. Apr 2003 B1
6551250 Khalil Apr 2003 B2
6566648 Froggatt May 2003 B1
6570894 Anderson May 2003 B2
6572555 White et al. Jun 2003 B2
6579311 Makower Jun 2003 B1
6584335 Haar et al. Jun 2003 B1
6592612 Samson et al. Jul 2003 B1
6594448 Herman et al. Jul 2003 B2
6602241 Makower et al. Aug 2003 B2
6611322 Nakayama et al. Aug 2003 B1
6611720 Hata et al. Aug 2003 B2
6612992 Hossack et al. Sep 2003 B1
6615062 Ryan et al. Sep 2003 B2
6615072 Izatt et al. Sep 2003 B1
6621562 Durston Sep 2003 B2
6631284 Nutt et al. Oct 2003 B2
6638227 Bae Oct 2003 B2
6645152 Jung et al. Nov 2003 B1
6646745 Verma et al. Nov 2003 B2
6655386 Makower et al. Dec 2003 B1
6659957 Vardi et al. Dec 2003 B1
6660024 Flaherty et al. Dec 2003 B1
6663565 Kawagishi et al. Dec 2003 B2
6665456 Dave et al. Dec 2003 B2
6669716 Gilson et al. Dec 2003 B1
6671055 Wavering et al. Dec 2003 B1
6673015 Glover et al. Jan 2004 B1
6673064 Rentrop Jan 2004 B1
6685648 Flaherty et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6689144 Gerberding Feb 2004 B2
6696173 Naundorf et al. Feb 2004 B1
6701044 Arbore et al. Mar 2004 B2
6701176 Halperin et al. Mar 2004 B1
6709444 Makower Mar 2004 B1
6712836 Berg et al. Mar 2004 B1
6714703 Lee et al. Mar 2004 B2
6719717 Johnson et al. Apr 2004 B1
6725073 Motamedi et al. Apr 2004 B1
6726677 Flaherty et al. Apr 2004 B1
6730107 Kelley et al. May 2004 B2
6733474 Kusleika May 2004 B2
6738144 Dogariu May 2004 B1
6740113 Vrba May 2004 B2
6746464 Makower Jun 2004 B1
6780157 Stephens et al. Aug 2004 B2
6795188 Ruck et al. Sep 2004 B2
6795196 Funakawa Sep 2004 B2
6798522 Stolte et al. Sep 2004 B2
6822798 Wu et al. Nov 2004 B2
6830559 Schock Dec 2004 B2
6832024 Gerstenberger et al. Dec 2004 B2
6842639 Winston et al. Jan 2005 B1
6847449 Bashkansky et al. Jan 2005 B2
6855115 Fonseca et al. Feb 2005 B2
6856138 Bohley Feb 2005 B2
6856400 Froggatt Feb 2005 B1
6856472 Herman et al. Feb 2005 B2
6860867 Seward et al. Mar 2005 B2
6866670 Rabiner et al. Mar 2005 B2
6878113 Miwa et al. Apr 2005 B2
6886411 Kjellman et al. May 2005 B2
6891984 Petersen et al. May 2005 B2
6895106 Wang et al. May 2005 B2
6898337 Averett et al. May 2005 B2
6900897 Froggatt May 2005 B2
6912051 Jensen Jun 2005 B2
6916329 Zhao Jul 2005 B1
6922498 Shah Jul 2005 B2
6937346 Nebendahl et al. Aug 2005 B2
6937696 Mostafavi Aug 2005 B1
6943939 DiJaili et al. Sep 2005 B1
6947147 Motamedi et al. Sep 2005 B2
6947787 Webler Sep 2005 B2
6949094 Yaron Sep 2005 B2
6952603 Gerber et al. Oct 2005 B2
6954737 Kalantar et al. Oct 2005 B2
6958042 Honda Oct 2005 B2
6961123 Wang et al. Nov 2005 B1
6966891 Ookubo et al. Nov 2005 B2
6969293 Thai Nov 2005 B2
6969395 Eskuri Nov 2005 B2
6985234 Anderson Jan 2006 B2
7004963 Wang et al. Feb 2006 B2
7006231 Ostrovsky et al. Feb 2006 B2
7010458 Wilt Mar 2006 B2
7024025 Sathyanarayana Apr 2006 B2
7027211 Ruffa Apr 2006 B1
7027743 Tucker et al. Apr 2006 B1
7033347 Appling Apr 2006 B2
7035484 Silberberg et al. Apr 2006 B2
7037269 Nix et al. May 2006 B2
7042573 Froggatt May 2006 B2
7044915 White et al. May 2006 B2
7044964 Jang et al. May 2006 B2
7048711 Rosenman et al. May 2006 B2
7049306 Konradi et al. May 2006 B2
7058239 Singh et al. Jun 2006 B2
7060033 White et al. Jun 2006 B2
7060421 Naundorf et al. Jun 2006 B2
7063679 Maguire et al. Jun 2006 B2
7068852 Braica Jun 2006 B2
7074188 Nair et al. Jul 2006 B2
7095493 Harres Aug 2006 B2
7110119 Maestle Sep 2006 B2
7113875 Terashima et al. Sep 2006 B2
7123777 Rondinelli et al. Oct 2006 B2
7130054 Ostrovsky et al. Oct 2006 B2
7139440 Rondinelli et al. Nov 2006 B2
7153299 Tu et al. Dec 2006 B1
7171078 Sasaki et al. Jan 2007 B2
7175597 Vince et al. Feb 2007 B2
7177491 Dave et al. Feb 2007 B2
7190464 Alphonse Mar 2007 B2
7215802 Klingensmith et al. May 2007 B2
7218811 Shigenaga et al. May 2007 B2
7236812 Ballerstadt et al. Jun 2007 B1
7245125 Harer et al. Jul 2007 B2
7245789 Bates et al. Jul 2007 B2
7249357 Landman et al. Jul 2007 B2
7291146 Steinke et al. Nov 2007 B2
7292715 Furnish Nov 2007 B2
7292885 Scott et al. Nov 2007 B2
7294124 Eidenschink Nov 2007 B2
7300460 Levine et al. Nov 2007 B2
7335161 Von Arx et al. Feb 2008 B2
7337079 Park et al. Feb 2008 B2
7355716 de Boer et al. Apr 2008 B2
7356367 Liang et al. Apr 2008 B2
7358921 Snyder et al. Apr 2008 B2
7359062 Chen et al. Apr 2008 B2
7359554 Klingensmith et al. Apr 2008 B2
7363927 Ravikumar Apr 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7387636 Cohn et al. Jun 2008 B2
7391520 Zhou et al. Jun 2008 B2
7397935 Kimmel et al. Jul 2008 B2
7399095 Rondinelli Jul 2008 B2
7408648 Kleen et al. Aug 2008 B2
7414779 Huber et al. Aug 2008 B2
7440087 Froggatt et al. Oct 2008 B2
7447388 Bates et al. Nov 2008 B2
7449821 Dausch Nov 2008 B2
7450165 Ahiska Nov 2008 B2
7458967 Appling et al. Dec 2008 B2
7463362 Lasker et al. Dec 2008 B2
7463759 Klingensmith et al. Dec 2008 B2
7491226 Palmaz et al. Feb 2009 B2
7515276 Froggatt et al. Apr 2009 B2
7527594 Vardi et al. May 2009 B2
7534251 WasDyke May 2009 B2
7535797 Peng et al. May 2009 B2
7547304 Johnson Jun 2009 B2
7564949 Sattler et al. Jul 2009 B2
7577471 Camus et al. Aug 2009 B2
7583857 Xu et al. Sep 2009 B2
7603165 Townsend et al. Oct 2009 B2
7612773 Magnin et al. Nov 2009 B2
7633627 Choma et al. Dec 2009 B2
7645229 Armstrong Jan 2010 B2
7658715 Park et al. Feb 2010 B2
7660452 Zwirn et al. Feb 2010 B2
7660492 Bates et al. Feb 2010 B2
7666204 Thornton et al. Feb 2010 B2
7672790 McGraw et al. Mar 2010 B2
7680247 Atzinger et al. Mar 2010 B2
7684991 Stohr et al. Mar 2010 B2
7711413 Feldman et al. May 2010 B2
7720322 Prisco May 2010 B2
7728986 Lasker et al. Jun 2010 B2
7734009 Brunner et al. Jun 2010 B2
7736317 Stephens et al. Jun 2010 B2
7742795 Stone et al. Jun 2010 B2
7743189 Brown et al. Jun 2010 B2
7762954 Nix et al. Jul 2010 B2
7766896 Kornkven Volk et al. Aug 2010 B2
7773792 Kimmel et al. Aug 2010 B2
7775981 Guracar et al. Aug 2010 B1
7777399 Eidenschink et al. Aug 2010 B2
7781724 Childers et al. Aug 2010 B2
7783337 Feldman et al. Aug 2010 B2
7787127 Galle et al. Aug 2010 B2
7792342 Barbu et al. Sep 2010 B2
7801343 Unal et al. Sep 2010 B2
7801590 Feldman et al. Sep 2010 B2
7813609 Petersen et al. Oct 2010 B2
7831081 Li Nov 2010 B2
7846101 Eberle et al. Dec 2010 B2
7853104 Oota et al. Dec 2010 B2
7853316 Milner et al. Dec 2010 B2
9107639 Arvidsson Aug 2015 B2
10076301 Millett Sep 2018 B2
20010007940 Tu et al. Jul 2001 A1
20010029337 Pantages et al. Oct 2001 A1
20010037073 White et al. Nov 2001 A1
20010046345 Snyder et al. Nov 2001 A1
20010049548 Vardi et al. Dec 2001 A1
20020034276 Hu et al. Mar 2002 A1
20020041723 Ronnekleiv et al. Apr 2002 A1
20020069676 Kopp et al. Jun 2002 A1
20020089335 Williams Jul 2002 A1
20020099289 Crowley Jul 2002 A1
20020163646 Anderson Nov 2002 A1
20020186818 Arnaud et al. Dec 2002 A1
20020196446 Roth et al. Dec 2002 A1
20020197456 Pope Dec 2002 A1
20030004412 Izatt et al. Jan 2003 A1
20030016604 Hanes Jan 2003 A1
20030018273 Corl et al. Jan 2003 A1
20030023153 Izatt et al. Jan 2003 A1
20030032886 Dgany et al. Feb 2003 A1
20030050871 Broughton Mar 2003 A1
20030065371 Satake Apr 2003 A1
20030069723 Hegde Apr 2003 A1
20030077043 Hamm et al. Apr 2003 A1
20030085635 Davidsen May 2003 A1
20030090753 Takeyama et al. May 2003 A1
20030092995 Thompson May 2003 A1
20030093059 Griffin et al. May 2003 A1
20030103212 Westphal et al. Jun 2003 A1
20030152259 Belykh et al. Aug 2003 A1
20030181802 Ogawa Sep 2003 A1
20030187369 Lewis et al. Oct 2003 A1
20030194165 Silberberg et al. Oct 2003 A1
20030195419 Harada Oct 2003 A1
20030208116 Liang et al. Nov 2003 A1
20030212491 Mitchell et al. Nov 2003 A1
20030219202 Loeb et al. Nov 2003 A1
20030220749 Chen et al. Nov 2003 A1
20030228039 Green Dec 2003 A1
20040015065 Panescu et al. Jan 2004 A1
20040023317 Motamedi et al. Feb 2004 A1
20040028333 Lomas Feb 2004 A1
20040037742 Jen et al. Feb 2004 A1
20040042066 Kinoshita et al. Mar 2004 A1
20040054287 Stephens Mar 2004 A1
20040067000 Bates et al. Apr 2004 A1
20040068161 Couvillon Apr 2004 A1
20040082844 Vardi et al. Apr 2004 A1
20040092830 Scott et al. May 2004 A1
20040106853 Moriyama Jun 2004 A1
20040111552 Arimilli et al. Jun 2004 A1
20040126048 Dave et al. Jul 2004 A1
20040143160 Couvillon Jul 2004 A1
20040146546 Gravett et al. Jul 2004 A1
20040186369 Lam Sep 2004 A1
20040186558 Pavonik et al. Sep 2004 A1
20040195512 Crosetto Oct 2004 A1
20040220606 Goshgarian Nov 2004 A1
20040225220 Rich Nov 2004 A1
20040239938 Izatt Dec 2004 A1
20040242990 Brister et al. Dec 2004 A1
20040248439 Gernhardt et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050013778 Green et al. Jan 2005 A1
20050031176 Hertel et al. Feb 2005 A1
20050036150 Izatt et al. Feb 2005 A1
20050078317 Law et al. Apr 2005 A1
20050101859 Maschke May 2005 A1
20050140582 Lee et al. Jun 2005 A1
20050140682 Sumanaweera et al. Jun 2005 A1
20050140981 Waelti Jun 2005 A1
20050140984 Hitzenberger Jun 2005 A1
20050147303 Zhou et al. Jul 2005 A1
20050165439 Weber et al. Jul 2005 A1
20050171433 Boppart et al. Aug 2005 A1
20050171438 Chen et al. Aug 2005 A1
20050182297 Gravenstein et al. Aug 2005 A1
20050196028 Kleen et al. Sep 2005 A1
20050197585 Brockway et al. Sep 2005 A1
20050213103 Everett et al. Sep 2005 A1
20050215942 Abrahamson et al. Sep 2005 A1
20050234445 Conquergood et al. Oct 2005 A1
20050243322 Lasker et al. Nov 2005 A1
20050249391 Kimmel et al. Nov 2005 A1
20050251567 Ballew et al. Nov 2005 A1
20050254059 Alphonse Nov 2005 A1
20050264823 Zhu et al. Dec 2005 A1
20060013523 Childlers et al. Jan 2006 A1
20060015126 Sher Jan 2006 A1
20060029634 Berg et al. Feb 2006 A1
20060036167 Shina Feb 2006 A1
20060038115 Maas Feb 2006 A1
20060039004 de Boer et al. Feb 2006 A1
20060041180 Viswanathan et al. Feb 2006 A1
20060045536 Arahira Mar 2006 A1
20060052700 Svanerudh Mar 2006 A1
20060055936 Yun et al. Mar 2006 A1
20060058622 Tearney et al. Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060067620 Shishkov et al. Mar 2006 A1
20060072808 Grimm et al. Apr 2006 A1
20060074442 Noriega et al. Apr 2006 A1
20060098927 Schmidt et al. May 2006 A1
20060100694 Globerman May 2006 A1
20060106375 Werneth et al. May 2006 A1
20060132790 Gutin Jun 2006 A1
20060135870 Webler Jun 2006 A1
20060142703 Carter et al. Jun 2006 A1
20060142733 Forsberg Jun 2006 A1
20060173299 Romley et al. Aug 2006 A1
20060179255 Yamazaki Aug 2006 A1
20060184048 Saadat Aug 2006 A1
20060187537 Huber et al. Aug 2006 A1
20060195269 Yeatman et al. Aug 2006 A1
20060204119 Feng et al. Sep 2006 A1
20060229591 Lee Oct 2006 A1
20060239312 Kewitsch et al. Oct 2006 A1
20060241342 Macaulay et al. Oct 2006 A1
20060241465 Huennekens Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060258895 Maschke Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060267756 Kates Nov 2006 A1
20060270976 Savage et al. Nov 2006 A1
20060276709 Khamene et al. Dec 2006 A1
20060279742 Tearney et al. Dec 2006 A1
20060279743 Boesser et al. Dec 2006 A1
20060285638 Boese et al. Dec 2006 A1
20060287595 Maschke Dec 2006 A1
20060293597 Johnson et al. Dec 2006 A1
20070015969 Feldman et al. Jan 2007 A1
20070016029 Donaldson et al. Jan 2007 A1
20070016034 Donaldson Jan 2007 A1
20070016062 Park et al. Jan 2007 A1
20070027390 Maschke et al. Feb 2007 A1
20070036417 Argiro et al. Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038121 Feldman et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070043292 Camus et al. Feb 2007 A1
20070043597 Donaldson Feb 2007 A1
20070049847 Osborne Mar 2007 A1
20070060973 Ludvig et al. Mar 2007 A1
20070065077 Childers et al. Mar 2007 A1
20070066888 Maschke Mar 2007 A1
20070066890 Maschke Mar 2007 A1
20070066983 Maschke Mar 2007 A1
20070084995 Newton et al. Apr 2007 A1
20070100226 Yankelevitz et al. May 2007 A1
20070135887 Maschke Jun 2007 A1
20070142707 Wiklof et al. Jun 2007 A1
20070156019 Larkin et al. Jul 2007 A1
20070161893 Milner et al. Jul 2007 A1
20070161896 Adachi et al. Jul 2007 A1
20070161963 Smalling Jul 2007 A1
20070162860 Muralidharan et al. Jul 2007 A1
20070165141 Srinivas et al. Jul 2007 A1
20070167710 Unal et al. Jul 2007 A1
20070167804 Park et al. Jul 2007 A1
20070191682 Rolland et al. Aug 2007 A1
20070201736 Klingensmith et al. Aug 2007 A1
20070206193 Pesach Sep 2007 A1
20070208276 Kornkven Volk et al. Sep 2007 A1
20070213669 Eskuri Sep 2007 A1
20070225220 Ming et al. Sep 2007 A1
20070225590 Ramos Sep 2007 A1
20070229801 Tearney et al. Oct 2007 A1
20070232872 Prough et al. Oct 2007 A1
20070232874 Ince Oct 2007 A1
20070232890 Hirota Oct 2007 A1
20070232891 Hirota Oct 2007 A1
20070232892 Hirota Oct 2007 A1
20070232893 Tanioka Oct 2007 A1
20070232933 Gille et al. Oct 2007 A1
20070238957 Yared Oct 2007 A1
20070247033 Eidenschink et al. Oct 2007 A1
20070250000 Magnin et al. Oct 2007 A1
20070250036 Volk et al. Oct 2007 A1
20070258094 Izatt et al. Nov 2007 A1
20070260138 Feldman et al. Nov 2007 A1
20070278389 Ajgaonkar et al. Dec 2007 A1
20070287914 Cohen Dec 2007 A1
20080002183 Yatagai et al. Jan 2008 A1
20080013093 Izatt et al. Jan 2008 A1
20080021275 Tearney et al. Jan 2008 A1
20080027481 Gilson et al. Jan 2008 A1
20080043024 Schiwietz et al. Feb 2008 A1
20080045842 Furnish Feb 2008 A1
20080051660 Kakadaris et al. Feb 2008 A1
20080063304 Russak et al. Mar 2008 A1
20080085041 Breeuwer Apr 2008 A1
20080095465 Mullick et al. Apr 2008 A1
20080095714 Castella et al. Apr 2008 A1
20080097194 Milner Apr 2008 A1
20080101667 Begelman et al. May 2008 A1
20080108867 Zhou May 2008 A1
20080114254 Matcovitch et al. May 2008 A1
20080119739 Vardi et al. May 2008 A1
20080124495 Horn et al. May 2008 A1
20080125772 Stone et al. May 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080143707 Mitchell Jun 2008 A1
20080146941 Dala-Krishna Jun 2008 A1
20080147111 Johnson et al. Jun 2008 A1
20080154128 Milner Jun 2008 A1
20080161696 Schmitt et al. Jul 2008 A1
20080171944 Brenneman et al. Jul 2008 A1
20080175465 Jiang et al. Jul 2008 A1
20080177183 Courtney et al. Jul 2008 A1
20080180683 Kemp Jul 2008 A1
20080181477 Izatt et al. Jul 2008 A1
20080187201 Liang et al. Aug 2008 A1
20080228086 Ilegbusi et al. Sep 2008 A1
20080247622 Aylward et al. Oct 2008 A1
20080247716 Thomas et al. Oct 2008 A1
20080262470 Lee et al. Oct 2008 A1
20080262489 Steinke Oct 2008 A1
20080269599 Csavoy et al. Oct 2008 A1
20080281205 Naghavi et al. Nov 2008 A1
20080281248 Angheloiu et al. Nov 2008 A1
20080285043 Fercher et al. Nov 2008 A1
20080287795 Klingensmith et al. Nov 2008 A1
20080291463 Milner et al. Nov 2008 A1
20080292173 Hsieh et al. Nov 2008 A1
20080294034 Krueger et al. Nov 2008 A1
20080298655 Edwards Dec 2008 A1
20080306766 Ozeki et al. Dec 2008 A1
20090009801 Tabuki Jan 2009 A1
20090018393 Dick et al. Jan 2009 A1
20090034813 Dikmen et al. Feb 2009 A1
20090043191 Castella et al. Feb 2009 A1
20090046295 Kemp et al. Feb 2009 A1
20090052614 Hempel et al. Feb 2009 A1
20090069843 Agnew Mar 2009 A1
20090079993 Yatagai et al. Mar 2009 A1
20090088650 Cort Apr 2009 A1
20090093980 Kemp et al. Apr 2009 A1
20090122320 Petersen et al. May 2009 A1
20090138544 Wegenkittl et al. May 2009 A1
20090149739 Maschke Jun 2009 A9
20090156941 Moore Jun 2009 A1
20090174886 Inoue Jul 2009 A1
20090174931 Huber et al. Jul 2009 A1
20090177090 Grunwald et al. Jul 2009 A1
20090177183 Pinkernell et al. Jul 2009 A1
20090192412 Sela Jul 2009 A1
20090195514 Glynn et al. Aug 2009 A1
20090196470 Carl et al. Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090203991 Papaioannou et al. Aug 2009 A1
20090264768 Courtney et al. Oct 2009 A1
20090269014 Winberg et al. Oct 2009 A1
20090270695 Mceowen Oct 2009 A1
20090284322 Harrison et al. Nov 2009 A1
20090284332 Moore et al. Nov 2009 A1
20090284749 Johnson et al. Nov 2009 A1
20090290167 Flanders et al. Nov 2009 A1
20090292048 Li et al. Nov 2009 A1
20090299195 Muller et al. Dec 2009 A1
20090299284 Holman et al. Dec 2009 A1
20090318951 Kashkarov et al. Dec 2009 A1
20090326634 Vardi Dec 2009 A1
20100007669 Bethune et al. Jan 2010 A1
20100030042 Denninghoff et al. Feb 2010 A1
20100056923 Hyun Mar 2010 A1
20100061611 Xu et al. Mar 2010 A1
20100063400 Hall et al. Mar 2010 A1
20100087732 Eberle et al. Apr 2010 A1
20100094125 Younge et al. Apr 2010 A1
20100094127 Xu Apr 2010 A1
20100094135 Fang-Yen et al. Apr 2010 A1
20100094143 Mahapatra et al. Apr 2010 A1
20100113919 Maschke May 2010 A1
20100125238 Lye et al. May 2010 A1
20100125268 Gustus et al. May 2010 A1
20100125648 Zaharia et al. May 2010 A1
20100128348 Taverner May 2010 A1
20100152717 Keeler Jun 2010 A1
20100160788 Davies et al. Jun 2010 A1
20100161023 Cohen et al. Jun 2010 A1
20100168714 Burke et al. Jul 2010 A1
20100179421 Tupin Jul 2010 A1
20100179426 Davies et al. Jul 2010 A1
20100220334 Condit et al. Sep 2010 A1
20100226607 Zhang et al. Sep 2010 A1
20100234736 Cori Sep 2010 A1
20100249601 Courtney Sep 2010 A1
20100256616 Katoh et al. Oct 2010 A1
20100272432 Johnson Oct 2010 A1
20100284590 Peng et al. Nov 2010 A1
20100290693 Cohen et al. Nov 2010 A1
20100331950 Strommer Dec 2010 A1
20110010925 Nix et al. Jan 2011 A1
20110021926 Spencer et al. Jan 2011 A1
20110025853 Richardson Feb 2011 A1
20110026797 Declerck et al. Feb 2011 A1
20110032533 Izatt et al. Feb 2011 A1
20110034801 Baumgart Feb 2011 A1
20110044546 Pan et al. Feb 2011 A1
20110066073 Kuiper et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110072405 Chen et al. Mar 2011 A1
20110077528 Kemp et al. Mar 2011 A1
20110080591 Johnson et al. Apr 2011 A1
20110087104 Moore et al. Apr 2011 A1
20110137140 Tearney et al. Jun 2011 A1
20110144502 Zhou et al. Jun 2011 A1
20110152771 Milner et al. Jun 2011 A1
20110157597 Lu et al. Jun 2011 A1
20110160586 Li et al. Jun 2011 A1
20110178413 Schmitt Jul 2011 A1
20110190586 Kemp Aug 2011 A1
20110196237 Pelissier Aug 2011 A1
20110216378 Poon et al. Sep 2011 A1
20110220985 Son et al. Sep 2011 A1
20110238061 van der Weide et al. Sep 2011 A1
20110238083 Moll et al. Sep 2011 A1
20110245669 Zhang Oct 2011 A1
20110249094 Wang et al. Oct 2011 A1
20110257545 Suri Oct 2011 A1
20110264125 Wilson et al. Oct 2011 A1
20110274329 Mathew et al. Nov 2011 A1
20110282334 Groenhoff Nov 2011 A1
20110301684 Fischell et al. Dec 2011 A1
20110306995 Moberg Dec 2011 A1
20110319752 Steinberg et al. Dec 2011 A1
20120004529 Tolkowsky et al. Jan 2012 A1
20120004668 Wallace et al. Jan 2012 A1
20120013914 Kemp et al. Jan 2012 A1
20120016344 Kusakabe Jan 2012 A1
20120016395 Olson Jan 2012 A1
20120022360 Kemp Jan 2012 A1
20120026503 Lewandowski et al. Feb 2012 A1
20120029007 Graham et al. Feb 2012 A1
20120059253 Wang et al. Mar 2012 A1
20120059368 Takaoka et al. Mar 2012 A1
20120062843 Ferguson et al. Mar 2012 A1
20120065481 Hunter et al. Mar 2012 A1
20120071823 Chen Mar 2012 A1
20120071838 Fojtik Mar 2012 A1
20120075638 Rollins et al. Mar 2012 A1
20120083696 Kitamura Apr 2012 A1
20120095340 Smith Apr 2012 A1
20120095372 Sverdlik et al. Apr 2012 A1
20120108943 Bates et al. May 2012 A1
20120113108 Dala-Krishna May 2012 A1
20120116353 Arnold et al. May 2012 A1
20120130243 Balocco et al. May 2012 A1
20120130247 Waters et al. May 2012 A1
20120136259 Milner et al. May 2012 A1
20120136427 Palmaz et al. May 2012 A1
20120137075 Vorbach May 2012 A1
20120155734 Barratt et al. Jun 2012 A1
20120158101 Stone et al. Jun 2012 A1
20120162660 Kemp Jun 2012 A1
20120165661 Kemp et al. Jun 2012 A1
20120170848 Kemp et al. Jul 2012 A1
20120170963 Lou Jul 2012 A1
20120172698 Teo et al. Jul 2012 A1
20120176607 Ott Jul 2012 A1
20120184853 Waters Jul 2012 A1
20120184859 Shah et al. Jul 2012 A1
20120184977 Wolf Jul 2012 A1
20120215094 Rahimian et al. Aug 2012 A1
20120220836 Alpert et al. Aug 2012 A1
20120220851 Razansky et al. Aug 2012 A1
20120220865 Brown et al. Aug 2012 A1
20120220874 Hancock et al. Aug 2012 A1
20120220883 Manstrom et al. Aug 2012 A1
20120224751 Kemp et al. Sep 2012 A1
20120226153 Brown et al. Sep 2012 A1
20120230565 Steinberg et al. Sep 2012 A1
20120232400 Dickinson et al. Sep 2012 A1
20120238869 Schmitt et al. Sep 2012 A1
20120238956 Yamada et al. Sep 2012 A1
20120244043 Leblanc et al. Sep 2012 A1
20120250028 Schmitt et al. Oct 2012 A1
20120253186 Simpson et al. Oct 2012 A1
20120253192 Cressman Oct 2012 A1
20120253276 Govari et al. Oct 2012 A1
20120257210 Whitney et al. Oct 2012 A1
20120262720 Brown et al. Oct 2012 A1
20120265077 Gille et al. Oct 2012 A1
20120265268 Blum et al. Oct 2012 A1
20120265296 McNamara et al. Oct 2012 A1
20120271170 Emelianov et al. Oct 2012 A1
20120271175 Moore et al. Oct 2012 A1
20120271339 O'Beirne et al. Oct 2012 A1
20120274338 Baks et al. Nov 2012 A1
20120276390 Ji et al. Nov 2012 A1
20120277722 Gerber et al. Nov 2012 A1
20120279764 Jiang et al. Nov 2012 A1
20120283758 Miller et al. Nov 2012 A1
20120289987 Wilson et al. Nov 2012 A1
20120299439 Huang Nov 2012 A1
20120310081 Adler et al. Dec 2012 A1
20120310332 Murray et al. Dec 2012 A1
20120319535 Dausch Dec 2012 A1
20120323075 Younge et al. Dec 2012 A1
20120323127 Boyden et al. Dec 2012 A1
20120330141 Brown et al. Dec 2012 A1
20130015975 Huennekens et al. Jan 2013 A1
20130023762 Huennekens et al. Jan 2013 A1
20130023763 Huennekens et al. Jan 2013 A1
20130026655 Lee et al. Jan 2013 A1
20130030295 Huennekens et al. Jan 2013 A1
20130030303 Ahmed Jan 2013 A1
20130030410 Drasler et al. Jan 2013 A1
20130053949 Pintor et al. Feb 2013 A1
20130066197 Pruvot Mar 2013 A1
20130109958 Baumgart et al. May 2013 A1
20130109959 Baumgart et al. May 2013 A1
20130137980 Waters et al. May 2013 A1
20130150716 Stigall et al. Jun 2013 A1
20130158594 Carrison et al. Jun 2013 A1
20130218201 Obermiller et al. Aug 2013 A1
20130218267 Braido et al. Aug 2013 A1
20130223789 Lee et al. Aug 2013 A1
20130223798 Jenner et al. Aug 2013 A1
20130296704 Magnin et al. Nov 2013 A1
20130303907 Cort Nov 2013 A1
20130303920 Cort Nov 2013 A1
20130310698 Judell et al. Nov 2013 A1
20130331820 Itou et al. Dec 2013 A1
20130338766 Hastings et al. Dec 2013 A1
20130339958 Droste et al. Dec 2013 A1
20140039294 Jiang Feb 2014 A1
20140121513 Tolkowsky May 2014 A1
20140180067 Stigall et al. Jun 2014 A1
20140180128 Cori Jun 2014 A1
20140181717 Lahti Jun 2014 A1
20140200438 Millett et al. Jul 2014 A1
20140229881 Schadewaldt Aug 2014 A1
Foreign Referenced Citations (80)
Number Date Country
1041373 Oct 2000 EP
01172637 Jan 2002 EP
2438877 Apr 2012 EP
2280261 Jan 1995 GB
2000-262461 Sep 2000 JP
2000-292260 Oct 2000 JP
2001-125009 May 2001 JP
2001-272331 Oct 2001 JP
2002-374034 Dec 2002 JP
2003-143783 May 2003 JP
2003-172690 Jun 2003 JP
2003-256876 Sep 2003 JP
2003-287534 Oct 2003 JP
2005-274380 Oct 2005 JP
2006-184284 Jul 2006 JP
2006-266797 Oct 2006 JP
2006-313158 Nov 2006 JP
2007-024677 Feb 2007 JP
2009-233001 Oct 2009 JP
2011-56786 Mar 2011 JP
9101156 Feb 1991 WO
9216865 Oct 1992 WO
9306213 Apr 1993 WO
9308829 May 1993 WO
9838907 Sep 1998 WO
9857583 Dec 1998 WO
0011511 Mar 2000 WO
00044296 Aug 2000 WO
0111409 Feb 2001 WO
03062802 Jul 2003 WO
03073950 Sep 2003 WO
2004010856 Feb 2004 WO
2004023992 Mar 2004 WO
2004096049 Nov 2004 WO
2005047813 May 2005 WO
2005106695 Nov 2005 WO
2006029634 Mar 2006 WO
2006037132 Apr 2006 WO
2006039091 Apr 2006 WO
2006061829 Jun 2006 WO
2006068875 Jun 2006 WO
2006111704 Oct 2006 WO
2006119416 Nov 2006 WO
2006121851 Nov 2006 WO
2006130802 Dec 2006 WO
2007002685 Jan 2007 WO
2007025230 Mar 2007 WO
2007045690 Apr 2007 WO
2007058895 May 2007 WO
2007067323 Jun 2007 WO
2007084995 Jul 2007 WO
2008058084 May 2008 WO
2008069991 Jun 2008 WO
2008107905 Sep 2008 WO
2009009799 Jan 2009 WO
2009009801 Jan 2009 WO
2009046431 Apr 2009 WO
2009121067 Oct 2009 WO
2009137704 Nov 2009 WO
201106886 Jan 2011 WO
2011038048 Mar 2011 WO
2011081688 Jul 2011 WO
2012003369 Jan 2012 WO
2012061935 May 2012 WO
2012071388 May 2012 WO
2012087818 Jun 2012 WO
2012098194 Jul 2012 WO
2012109676 Aug 2012 WO
2012130289 Oct 2012 WO
2012154767 Nov 2012 WO
2012155040 Nov 2012 WO
20120170963 Dec 2012 WO
2013033414 Mar 2013 WO
2013033415 Mar 2013 WO
2013033418 Mar 2013 WO
2013033489 Mar 2013 WO
2013033490 Mar 2013 WO
2013033592 Mar 2013 WO
2013126390 Aug 2013 WO
2014109879 Jul 2014 WO
Non-Patent Literature Citations (150)
Entry
Li et al., 2000, Optical Coherence Tomography: Advanced Technology for the Endoscopic Imaging of Barrett's Esophagus, Endoscopy, 32(12):921-930.
Little et al., 1991, The underlying coronary lesion in myocardial infarction:implications for coronary angiography, Clinica Cardiology, 14(11):868-874.
Loo, 2004, Nanoshell Enabled Photonics-Based Imaging and Therapy of Cancer, Technology in Cancer Research & Treatment 3(1):33-40.
Machine translation of JP 2000-097846.
Machine translation of JP 2000-321034.
Machine translation of JP 2000-329534.
Machine translation of JP 2004-004080.
Maintz et al., 1998, An Overview of Medical Image Registration Methods, Technical Report UU-CS, (22 pages).
Mamas et al., 2010, Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve, Journal of Invasive Cardiology 22(6):260-265.
Marks et al., 1991, By-passing Immunization Human Antibodies from V-gene Libraries Displayed on Phage, J. Mol. Biol. 222:581-597.
Marks et al., 1992, By-Passing Immunization:Building High Affinity Human Antibodies by Chain Shuffling, BioTechnol., 10:779-783.
Maruno et al., 1991, Fluorine containing optical adhesives for optical communications systems, J. Appl. Polymer. Sci. 42:2141-2148.
McCafferty et al., 1990, Phage antibodies: filamentous phage displaying antibody variable domains, Nature 348:552-554.
Mendieta et al., 1996, Complementary sequence correlations with applications to reflectometry studies, Instrumentation and Development 3(6):37-46.
Mickley, 2008, Steal Syndrome-strategies to preserve vascular access and extremity, Nephrol Dial Transplant 23:19-24.
Miller et al., 2010, The MILLER banding procedure is an effective method for treating dialysis-associated steal syndrome, Kidney International 77:359-366.
Milstein et al., 1983, Hybrid hybridomas and their use in immunohistochemistry, Nature 305:537-540.
Mindlin et al., 1936, A force at a point of a semi-infinite solid, Physics, 7:195-202.
Morrison et al., 1984, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains, PNAS 81:6851-6855.
Munson et al., 1980, Ligand: a versatile computerized approach for characterization of ligand-binding systems, Analytical Biochemistry, 107:220-239.
Nezam, 2008, High Speed Polygon-Scanner-Based Wavelength-Swept Laser Source in the Telescope-Less Configurations with Application in Optical Coherence Tomography, Optics Letters 33(15): 1741-1743.
Nissen, 2001, Coronary Angiography and Intravascular Ultrasound, American Journal of Cardiology, 87(suppl):15A-20A.
Nitenberg et al., 1995, Coronary vascular reserve in humans: a critical review of methods of evaluation and of interpretation of the results, Eur Heart J. 16(Suppl 1):7-21.
Notice of Reason(s) for Refusal dated Apr. 30, 2013, for Japanese Patent Application No. 2011-508677 for Optical Imaging Catheter for Aberation Balancing to Volcano Corporation, which application is a Japanese national stage entry of PCT/US2009/043181 with international filing date May 7, 2009, of the same title, published on Nov. 12, 2009, as WO 2009/137704, and accompanying English translation of the Notice of Reason(s) for Refusal and machine translations of JP11-56786 and JP2004-290548 (56 pages).
Nygren, 1982, Conjugation of horseradish peroxidase to Fab fragments with different homobifunctional and heterobifunctional cross-linking reagents. A comparative study, J. Histochem. and Cytochem. 30:407-412.
Oesterle et al., 1986, Angioplasty at coronary bifurcations: single-guide, two-wire technique, Cathet Cardiovasc Diagn., 12:57-63.
Okuno et al., 2003, Recent Advances in Optical Switches Using Silica-based PLC Technology, NTT Technical Review 1(7):20-30.
Oldenburg et al., 1998, Nanoengineering of Optical Resonances, Chemical Physics Letters 288:243-247.
Oldenburg et al., 2003, Fast-Fourier-Domain Delay Line for In Vivo Optical Coherence Tomography with a Polygonal Scanner, Applied Optics, 42(22):4606-4611.
Othonos, 1997, Fiber Bragg gratings, Review of Scientific Instruments 68(12):4309-4341.
Owens et al., 2007, A Survey of General-Purpose Computation on Graphics Hardware, Computer Graphics Forum 26(1):80-113.
Pain et al., 1981, Preparation of protein A-peroxidase mono conjugate using a heterobifunctional reagent, and its use in enzyme immunoassays, J Immunol Methods, 40:219-30.
Park et al., 2005, Real-time fiber-based multi-functional spectral-domain optical coherence tomography at 1.3 um., Optics Express 13(11):3931-3944.
Pasquesi et al., 2006, In vivo detection of exercise induced ultrastructural changes in genetically-altered murine skeletal muscle using polarization-sensitive optical coherence tomography, Optics Express 14(4):1547-1556.
Pepe et al., 2004, Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker, American Journal of Epidemiology 159(9):882-890.
Persson et al., 1985, Acoustic impedance matching of medical ultrasound transducers, Ultrasonics, 23(2):83-89.
Placht et al., 2012, Fast time-of-flight camera based surface registration for radiotherapy patient positioning, Medical Physics 39(1):4-17.
Rabbani et al., 1999, Review: Strategies to achieve coronary arterial plaque stabilization, Cardiovascular Research 41:402-417.
Radvany et al., 2008, Plaque Excision in Management of Lower Extremity Peripheral Arterial Disease with the SilverHawk Atherectomy Catheter, Seminars in Interventional Radiology, 25(1):11-19.
Reddy et al., 1996, An FFT-Based Technique for Translation, Rotation, and Scale-Invariant Image Registration, IEEE Transaction on Image Processing 5(8):1266-1271.
Riechmann et al., 1988, Reshaping human antibodies for therapy, Nature, 332:323-327.
Rivers et al., 1992, Correction of steal syndrome secondary to hemodialysis access fistulas: a simplified quantitative technique, Surgery, 112(3):593-7.
Robbin et al., 2002, Hemodialysis Arteriovenous Fistula Maturity: US Evaluation, Radiology 225:59-64.
Rollins et al., 1998, In vivo video rate optical coherence tomography, Optics Express 3:219-229.
Sarunic et al., 2005, Instantaneous Complex Conjugate Resolved Spectral Domain and Swept-Source OCT Using 3x3 Fiber Couplers, Optics Express 13(3):957-967.
Satiani et al., 2009, Predicted Shortage of Vascular Surgeons in the United States, J. Vascular Surgery 50:946-952.
Schneider et al., 2006, T-banding: A technique for flow reduction of a hyper-functioning arteriovenous fistula, J Vase Surg. 43(2):402-405.
Sen et al., 2012, Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis, Journal of the American College of Cardiology 59(15):1392-1402.
Setta et al., 2005, Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis, Human Reproduction, 20(11):3114-3121.
Seward et al., 1996, Ultrasound Cardioscopy: Embarking on New Journey, Mayo Clinic Proceedings 71(7):629-635.
International Search Report and Written Opinion mailed Nov. 2, 2012, for International Patent Application No. PCT/US12/53168, filed Aug. 30, 2013 (8 pages).
International Search Report and Written Opinion mailed on Apr. 14, 2014, for International Patent Application No. PCT/US2013/076148, filed Dec. 18, 2013 (8 pages).
International Search Report and Written Opinion mailed on Apr. 21, 2014, for International Patent Application No. PCT/US2013/076015, filed Dec. 18, 2013 (7 pages).
International Search Report and Written Opinion mailed on Apr. 23, 2014, for International Patent Application No. PCT/US2013/075328, filed Dec. 16, 2013 (8 pages).
International Search Report and Written Opinion mailed on Apr. 29, 2014, for International Patent Application No. PCT/US13/76093, filed Dec. 18, 2013 (6 pages).
International Search Report and Written Opinion mailed on Apr. 9, 2014, for International Patent Application No. PCT/US13/75089, filed Dec. 13, 2013 (7 pages).
International Search Report and Written Opinion mailed on Feb. 21, 2014, for International Patent Application No. PCT/US13/76053, filed Dec. 18, 2013 (9 pages).
International Search Report and Written Opinion mailed on Feb. 21, 2014, for International Patent Application No. PCT/US2013/076965, filed Dec. 20, 2013 (6 pages).
International Search Report and Written Opinion mailed on Feb. 27, 2014, for International Patent Application No. PCT/US13/75416, filed Dec. 16, 2013 (7 pages).
International Search Report and Written Opinion mailed on Feb. 28, 2014, for International Patent Application No. PCT/US13/75653, filed Dec. 17, 2013 (7 pages).
International Search Report and Written Opinion mailed on Feb. 28, 2014, for International Patent Application No. PCT/US13/75990, filed Dec. 18, 2013 (7 pages).
International Search Report and Written Opinion mailed on Jan. 16, 2009, for International Patent Application No. PCT/US08/78963 filed on Oct. 6, 2008 (7 Pages).
International Search Report and Written Opinion mailed on Jul. 16, 2014, for International Patent Application No. PCT/US2014/023241, filed Mar. 11, 2014 (14 pages).
International Search Report and Written Opinion mailed on Jul. 30, 2014, for International Patent Application No. PCT/US14/21659, filed Mar. 7, 2014 (15 pages).
International Search Report and Written Opinion mailed on Mar. 10, 2014, for International Patent Application No. PCT/US2013/076212, filed Dec. 18, 2013 (8 pages).
International Search Report and Written Opinion mailed on Mar. 11, 2014, for International Patent Application No. PCT/US13/76173, filed Dec. 16, 2013 (9 pages).
International Search Report and Written Opinion mailed on Mar. 11, 2014, for International Patent Application No. PCT/US13/76449, filed Dec. 19, 2013 (9 pages).
International Search Report and Written Opinion mailed on Mar. 18, 2014, for International Patent Application No. PCT/US2013/076502, filed Dec. 19, 2013 (7 pages).
International Search Report and Written Opinion mailed on Mar. 18, 2014, for International Patent Application No. PCT/US2013/076788, filed Dec. 20, 2013 (7 pages).
International Search Report and Written Opinion mailed on Mar. 19, 2014, for International Patent Application No. PCT/US13/75349, filed Dec. 16, 2013 (10 pages).
International Search Report and Written Opinion mailed on Mar. 19, 2014, for International Patent Application No. PCT/US2013/076587, filed Dec. 19, 2013 (10 pages).
International Search Report and Written Opinion mailed on Mar. 19, 2014, for International Patent Application No. PCT/US2013/076909, filed Dec. 20, 2013 (7 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076304, filed Dec. 18, 2013 (9 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076480, filed Dec. 19, 2013 (8 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076512, filed Dec. 19, 2013 (8 pages).
International Search Report and Written Opinion mailed on Mar. 7, 2014, for International Patent Application No. PCT/US2013/076531, filed Dec. 19, 2013 (10 pages).
Jakobovits et al., 1993, Analysis of homozygous mutant chimeric mice:deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production, PNAS USA 90:2551-255.
Jakobovits et al., 1993, Germ-line transmission and expression of a human-derived yeast artificial chromosome, Nature 362:255-258.
Jang et al., 2002, Visualization of Coronary Atherosclerotic Plaques in Patients Using Optical Coherence Tomography: Comparison With Intravascular Ultrasound, Journal of the American College of Cardiology 39:604-609.
Jiang et al., 1992, Image registration of multimodality 3-D medical images by chamfer matching, Proc. SPIE 1660, Biomedical Image Processing and Three-Dimensional Microscopy, 356-366.
Johnson et al., 1993, Human antibody engineering: Current Opinion in Structural Biology, 3:564-571.
Jones et al., 1986, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, 321:522-525.
Juviler et al., 2008, Anorectal sepsis and fistula-in-ano, Surgical Technology International, 17:139-149.
Karapatis et al., 1998, Direct rapid tooling:a review of current research, Rapid Prototyping Journal, 4(2):77-89.
Karp et al., 2009, The benefit of time-of-flight in PET imaging, J Nucl Med 49:462-470.
Kelly et al., 2005, Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle, Circulation Research 96:327-336.
Kemp et al., 2005, Depth Resolved Optic Axis Orientation in Multiple Layered Anisotropic Tissues Measured with Enhanced Polarization Sensitive Optical Coherence Tomography, Optics Express 13(12):4507-4518.
Kersey et al., 1991, Polarization insensitive fiber optic Michelson interferometer, Electron. Lett. 27:518-520.
Kheir et al., 2012, Oxygen Gas-Filled Microparticles Provide Intravenous Oxygen Delivery, Science Translational Medicine 4(140):140ra88 (10 pages).
Khuri-Yakub et al., 2011, Capacitive micromachined ultrasonic transducers for medical imaging and therapy, J Micromech Microeng. 21(5):054004-054014.
Kirkman, 1991, Technique for flow reduction in dialysis access fistulas, Surg Gyn Obstet, 172(3):231-3.
Kohler et al., 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, 256:495-7.
Koo et al., 2011, Diagnosis of IschemiaCausing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms, J Am Coll Cardiol 58(19):1989-1997.
Kozbor et al., 1984, A human hybrid myeloma for production of human monoclonal antibodies, J. Immunol., 133:3001-3005.
Kruth et al., 2003, Lasers and materials in selective laser sintering, Assembly Automation, 23(4):357-371.
Kumagai et al., 1994, Ablation of polymer films by a femtosecond high-peak-power Ti:sapphire laser at 798 nm, Applied Physics Letters, 65(14):1850-1852.
Larin et al., 2002, Noninvasive Blood Glucose Monitoring with Optical Coherence Tomography: a pilot study in human subjects, Diabetes Care, 25(12):2263-7.
Larin et al., 2004, Measurement of Refractive Index Variation of Physiological Analytes using Differential Phase OCT, Proc of SPIE 5325:31-34.
Laufer, 1996, Introduction to Optics and Lasers in Engineering, Cambridge University Press, Cambridge UK:156-162.
Lefevre et al., 2001, Stenting of bifurcation lesions:a rational approach, J. Interv. Cardiol., 14(6):573-585.
Abdi et al., 2010, Principal component analysis, Wiley Interdisciplinary Reviews: Computational Statistics 2:433-459.
Adler et al., 2007, Phase-Sensitive Optical Coherence Tomography at up to 370,000 Lines Per Second Using Buffered Fourier Domain Mode-Locked Lasers, Optics Letters, 32(6):626-628.
Agresti, 1996, Models for Matched Pairs, Chapter 8, An Introduction to Categorical Data Analysis, Wiley-Interscience A John Wiley & Sons, Inc., Publication, Hoboken, New Jersey.
Akasheh et al., 2004, Development of piezoelectric micromachined ultrasonic transducers, Sensors and Actuators A Physical, 111:275-287.
Amini et al., 1990, Using dynamic programming for solving variational problems in vision, IEEE Transactions on Pattern Analysis and Machine Intelligence, 12(9):855-867.
Bail et al., 1996, Optical coherence tomography with the “Spectral Radar”—Fast optical analysis in volume scatterers by short coherence interferometry, Optics Letters 21(14):1087-1089.
Bain, 2011, Privacy protection and face recognition, Chapter 3, Handbook of Face Recognition, Stan et al., Springer-Verlag.
Barnea et al., 1972, A class of algorithms for fast digital image registration, IEEE Trans. Computers, 21(2):179-186.
Blanchet et al., 1993, Laser Ablation and the Production of Polymer Films, Science, 262(5134):719-721.
Bonnema, 2008, Imaging Tissue Engineered Blood Vessel Mimics with Optical Tomography, College of Optical Sciences dissertation, University of Arizona (252 pages).
Bouma et al., 1999, Power-efficient nonreciprocal interferometer and linear-scanning fiber-optic catheter for optical coherence tomography, Optics Letters, 24(8):531-533.
Breiman, 2001, Random forests, Machine Learning 45:5-32.
Brown, 1992, A survey of image registration techniques, ACM Computing Surveys 24(4):325-376.
Bruining et al., 2009, Intravascular Ultrasound Registration/Integration with Coronary Angiography, Cardiology Clinics, 27(3):531-540.
Brummer, 1997, An euclidean distance measure between covariance matrices of speechcepstra for text-independent speaker recognition, in Proc. South African Symp. Communications and Signal Processing:167-172.
Burr et al., 2005, Searching for the Center of an Ellipse in Proceedings of the 17th Canadian Conference on Computational Geometry:260-263.
Canny, 1986, A computational approach to edge detection, IEEE Trans. Pattern Anal. Mach. Intell. 8:679-698.
Cavalli et al., 2010, Nanosponge formulations as oxygen delivery systems, International Journal of Pharmaceutics 402:254-257.
Choma et al., 2003, Sensitivity Advantage of Swept Source and Fourier Domain Optical Coherence Tomography, Optics Express 11(18):2183-2189 .
Clarke et al., 1995, Hypoxia and myocardial ischaemia during peripheral angioplasty, Clinical Radiology, 50(5):301-303.
Collins, 1993, Coronary flow reserve, British Heart Journal 69:279-281.
Communication Mechanisms for Distributed Real-Time Applications, NI Developer Zone, http://zone.ni.com/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007.
Cook, 2007, Use and misuse of receiver operating characteristic curve in risk prediction, Circulation 115(7):928-35.
D'Agostino et al., 2001, Validation of the Framingham coronary heart disease prediction score: results of a multiple ethnic group investigation, JAMA 286:180-187.
David et al., 1974, Protein iodination with solid-state lactoperoxidase, Biochemistry 13:1014-1021.
Davies et al., 1985, Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, British Heart Journal 53:363-373.
Davies et al., 1993, Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content, British Heart Journal 69:377-381.
Deterministic Data Streaming in Distributed Data Acquisition Systems, NI Developer Zone, “What is Developer Zone?”, http://zone.ni.com/devzone/cda/tut/p/id/3105, accessed Jul. 23, 2007.
Eigenwillig, 2008, K-Space Linear Fourier Domain Mode Locked Laser and Applications for Optical Coherence Tomography, Optics Express 16(12):8916-8937.
Elghanian et al., 1997, Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles, Science, 277(5329):1078-1080.
Ergun et al., 2003, Capacitive Micromachined Ultrasonic Transducers:Theory and Technology, Journal of Aerospace Engineering, 16(2):76-84.
Evans et al., 2006, Optical coherence tomography to identify intramucosa carcinoma and high-grade dysplasia in Barrett's esophagus, Clin Gast Hepat 4(1):38-43.
Fatemi et al., 1999, Vibro-acoustography: an imaging modality based on ultrasound-stimulated acoustic emission, PNAS U.S.A., 96(12):6603-6608.
Felzenszwalb et al., 2005, Pictorial Structures for Object Recognition, International Journal of Computer Vision, 61(1):55-79.
Ferring et al., 2008, Vasculature ultrasound for the pre-operative evaluation prior to arteriovenous fistula formation for haemodialysis: review of the evidence, Nephrol. Dial. Transplant. 23(6):1809-1815.
Fischler et al., 1973, The representation and matching of pictorial structures, IEEE Transactions on Computer 22:67-92.
Fleming et al., 2010, Real-time monitoring of cardiac radio-frequency ablation lesion formation using an optical coherence tomography forward-imaging catheter, Journal of Biomedical Optics 15 (3):030516-1 (3 pages).
Fookes et al., 2002, Rigid and non-rigid image registration and its association with mutual information:A review, Technical Report ISBN:1 86435 569 7, RCCVA, QUT.
Forstner & Moonen, 1999, A metric for covariance matrices, In Technical Report of the Dpt of Geodesy and Geoinformatics, Stuttgart University, 113-128.
Goel et al., 2006, Minimally Invasive Limited Ligation Endoluminal-assisted Revision (MILLER) for treatment of dialysis access-associated steal syndrome, Kidney Int 70(4):765-70.
Gotzinger et al., 2005, High speed spectral domain polarization sensitive optical coherence tomography of the human retina, Optics Express 13(25):10217-10229.
Gould et al., 1974, Physiologic basis for assessing critical coronary stenosis, American Journal of Cardiology, 33:87-94.
Griffiths et al., 1993, Human anti-self antibodies with high specificity from phage display libraries, The EMBO Journal, 12:725-734.
Griffiths et al., 1994, Isolation of high affinity human antibodies directly from large synthetic repertoires, The EMBO Journal, 13(14):3245-3260.
Grund et al., 2010, Analysis of biomarker data:logs, odds, ratios and ROC curves, Curr Opin HIV AIDS 5(6):473-479.
Harrison et al., 2011, Guidewire Stiffness: What's in a name?, J Endovasc Ther, 18(6):797-801.
Huber et al., 2005, Amplified, Frequency Swept Lasers for Frequency Domain Reflectometry and OCT Imaging: Design and Scaling Principles, Optics Express 13(9):3513-3528.
Huber et al., 2006, Fourier Domain Mode Locking (FDML): A New Laser Operating Regime and Applications for Optical Coherence Tomography, Optics Express 14(8):3225-3237.
International Search Report and Written Opinion mailed Mar. 11, 2014, for International Patent Application No. PCT/US13/75675, filed Dec. 17, 2013 (7 pages).
International Search Report and Written Opinion mailed Mar. 19, 2014, for International Patent Application No. PCT/US13/075353, filed Dec. 16, 2013 (8 pages).
Related Publications (1)
Number Date Country
20200260964 A1 Aug 2020 US
Provisional Applications (1)
Number Date Country
61776863 Mar 2013 US
Continuations (1)
Number Date Country
Parent 14204277 Mar 2014 US
Child 16865870 US